Virginia Commonwealth University

VCU Scholars Compass
Theses and Dissertations

Graduate School

2019

Phenotypic Characterization of PNPase Mutation and
Overexpression in C. elegans
Brian J. Hur

Follow this and additional works at: https://scholarscompass.vcu.edu/etd
Part of the Genetics Commons, and the Molecular Genetics Commons
© The Author

Downloaded from
https://scholarscompass.vcu.edu/etd/6092

This Thesis is brought to you for free and open access by the Graduate School at VCU Scholars Compass. It has
been accepted for inclusion in Theses and Dissertations by an authorized administrator of VCU Scholars Compass.
For more information, please contact libcompass@vcu.edu.

1

PHENOTYPIC CHARACTERIZATION OF PNPASE MUTATION AND
OVEREXPRESSION IN C. ELEGANS

A thesis submitted in partial fulfillment of the requirements for the degree of Master of Science
at Virginia Commonwealth University
By
Brian Hur
Bachelor of Science, College of William and Mary 2016

Director: RITA SHIANG, Ph.D.
Associate Professor
Department of Human and Molecular Genetics

Virginia Commonwealth University
Richmond, Virginia
November, 2019

2

Acknowledgement
First and foremost, I would like to express my deepest appreciation for my advisor and
mentor, Dr. Rita Shiang for everything related to this project. This project was only possible
with her patience and relentless support that allowed me to become a better scientist. Even at the
lowest points of the project, constant guidance and assistance from Dr. Rita Shiang allowed me
to stay focused and motivated to see this thesis to its completion.
I am extremely grateful for both of my committee members, Dr. James Lister and Dr.
Laura Mathies, for their expertise and unwavering assistance to make this project possible. Their
constant availability and willingness to take all of my questions, both large and small, was vital
and it was an experience I will never forget.
I would like to extend my sincere thanks to Dr. Jill Bettinger for her expertise with C.
elegans and providing initial yet vital advice at the start of my project.
Many thanks to Dr. Eun Lee and Dr. Maria Teves for their suggestions and contributions
when I needed help with protocol optimizations. Their support was a huge contribution that
allowed the completion of this project.
I’d like to recognize the assistance I received from Dr. McVoy when I needed to borrow
any equipment for my experiments and during my -80°C freezer troubles. Additionally, I very
much appreciated his advice on navigating graduate school.
I would also like to thank Dr. Gail Christie for giving me a chance and accepting me into
the graduate program. Being able to participate in this program was an amazing opportunity and
for that, I am forever grateful.
I would also like to extend my deepest gratitude to Dr. Diane Shakes and the SB347
Worm Crew. I would not be where I am nor be who I am right now without the research lab

3

opportunity you gave me during my time at William and Mary. Even after graduating, your
constant support and insight was instrumental and allowed me to succeed as a graduate student.
To the SB347 Worm Crew, many thanks for your constant support during my time in graduate
school.
I gratefully acknowledge the assistance and effort given from all current and past
members of the Shiang Lab who have helped me on this endeavor. I would not have been able to
do this project alone and your help allowed to see this project come to fruition.
Lastly, thank you to my family who have given me their unwavering support in times of
need. Their love and encouragement were paramount and provided a big motivational boost.

4

Clarification of Contributions

Creation of overexpression models with microinjections of the plasmids and constructs were
carried out by Dr. Laura Mathies.

Mutant strains (G58E (VC40327), G74R (VC20261), and G74E (VC20284) from the
Caenorhabditis Genetics Center were ordered by Dr. Laura Mathies and Dr. Jill Bettinger

Immunofluorescence reagents, Poly-L-Lysine, and Levamisole were obtained from Dr. Diane
Shakes at the College of William and Mary.

RIPA Buffer, resolving gel buffer, stacking gel buffer, Lowry Assay reagents were donated by
Dr. Maria Teves.

The pTG96 gfp reporter vector was a gift from Dr. Laura Mathies

T74 B4-7 dpy-10 bacterial strain was a gift from Dr. Jill Bettinger

1-F308 gld-1 bacterial strain was a gift from Dr. Malene Hansen

Clone of wpnpt-1 fragment 1+2 used for Fusion PCR was made by Laura Lambert.

5

Worm expression vector pPD49.83 was synthesized by Dr. Andrew Fire and obtained from the
Fire Lab C. elegans Vector Kit.

6

Table of Contents
Acknowledgements ........................................................................................................................ 2
Clarification of Contributions ........................................................................................................ 4
List of Tables and Figures ............................................................................................................ 11
List of Abbreviations ................................................................................................................... 14
Abstract ........................................................................................................................................ 17
Chapter
1. INTRODUCTION ........................................................................................................... 18
a. PNPase ................................................................................................................. 18
b. PNPase Structure.................................................................................................. 19
c. PNPase Localization............................................................................................. 21
d. Functional Studies – Mouse Knockout and Cellular Knockdown ....................... 22
e. Functional Studies – Cellular Overexpression ..................................................... 23
f. PNPase in the Mitochondria ................................................................................ 24
g. Human Diseases ................................................................................................... 26
h. ROS ...................................................................................................................... 29
i. C. elegans ............................................................................................................. 30
j. PNPase in C. elegans ........................................................................................... 31
k. C. elegans Germline ............................................................................................. 32
l. gld-1 Cancer Model in C. elegans ....................................................................... 35
m. Preliminary Studies of PNPase Knockdown in C. elegans .................................. 37
n. Project Outline ..................................................................................................... 38

7

2. MATERIALS AND METHODS
a. OP50 Liquid Cultures/Seeding NGM Plates ....................................................... 39
b. C. elegans Maintenance ....................................................................................... 39
c. C. elegans Strains ................................................................................................. 39
d. Frozen Stocks of Worms ...................................................................................... 40
e. RNAi Bacterial Strains ........................................................................................ 40
f. Extracting DNA from C. elegans ......................................................................... 41
g. Extracting RNA from C. elegans ......................................................................... 41
h. Generating cDNA ................................................................................................ 42
i. PCR ...................................................................................................................... 43
j. qPCR .................................................................................................................... 44
k. Analysis of C. elegans pnpt-1 Point Mutations ................................................... 45
l. Determination of Mitochondrial Targeting Peptide (mTP) ................................. 45
m. Male C. elegans generation .................................................................................. 45
n. Backcrossing ........................................................................................................ 46
o. PCR Purification and Concentration .................................................................... 49
p. Sequencing ........................................................................................................... 49
q. Gel Electrophoresis .............................................................................................. 50
r. Gel Extraction ...................................................................................................... 50
s. TA Cloning .......................................................................................................... 50
t. Gibson Assembly ................................................................................................. 51
u. PCR Fusion .......................................................................................................... 52
i. Fusion PCR – Step 1................................................................................. 53

8
ii. Fusion PCR – Step 2A ............................................................................. 54
iii. Fusion PCR – Step 2B ............................................................................. 55
iv. Fusion PCR – Step 3A ............................................................................. 56
v. Fusion PCR – Step 3B ............................................................................. 56
v. pnpt-1 Overexpression Transgenic Line Generation ........................................... 57
w. Transgenic Line Stabilization .............................................................................. 57
x. Overexpression of pnpt-1 ..................................................................................... 58
y. Western Protocol .................................................................................................. 58
i. Protein Extraction .................................................................................... 58
ii. Lowry Protein Assay ................................................................................ 59
iii. Western Analysis ..................................................................................... 60
iv. Block / Primary Ab / Secondary Ab ........................................................ 60
v. Detection .................................................................................................. 61
vi. Stripping ................................................................................................... 62
z. Immunofluorescence ............................................................................................ 62
i. Poly-L-Lysine Slide Preparation .............................................................. 62
ii. Edgar Buffer Dissecting Media ............................................................... 62
iii. Gonad Isolation ........................................................................................ 63
iv. Fixation .................................................................................................... 63
aa. ROS Assay ........................................................................................................... 65
3. RESULTS
a. Mutant Studies of PNPase in C. elegans ............................................................. 72
i. Missense Mutation Analysis .................................................................... 72

9

ii. Endogenous PNPase Expression of Mutants ........................................... 75
iii. Polycistronic Transcript Accumulation ................................................... 76
iv. ROS Assay ............................................................................................... 79
b. Overexpression Studies........................................................................................ 80
i. Generation of Transgenic Lines ............................................................... 81
ii. Determination of Heat Shock Protocols .................................................. 82
iii. Exogenous pnpt-1 Expression .................................................................. 84
iv. Total (Endogenous and Exogenous) pnpt-1 Expression .......................... 86
v. Exogenous PNPase Expression ................................................................ 87
vi. Polycistronic Transcript Accumulation ................................................... 88
vii. Total Mitochondrial Transcript ................................................................ 89
viii. ROS Assay ............................................................................................... 90
c. Cancer Model Studies .......................................................................................... 92
i. Heat Shock Protocol Optimization for Cancer Models ........................... 92
ii. Oocyte Formation .................................................................................... 93
iii. P-Granule Immunohistochemistry ........................................................... 94
4. DISCUSSION
a. Knockdown Studies ........................................................................................... 102
b. Mutant Studies ................................................................................................... 105
c. Overexpression Studies ...................................................................................... 108
d. Temporal Regulation of PNPase Expression in the Germline ........................... 112
e. PNPase Senescence of Differentiation in the Germline .................................... 113
f. Additional Future Directions ............................................................................. 116

10
5. CONCLUSION .............................................................................................................. 118
6. LITERATURE CITED .................................................................................................. 119
7. APPENDIX
a. NGM Plates (Nematode Growth Media) ........................................................... 127
b. M9 Buffer ........................................................................................................... 127
c. 1X Transfer Buffer ............................................................................................. 127
d. Knockdown Studies of PNPase in C. elegans ................................................... 128
i. PNPase Expression ................................................................................ 128
ii. Polycistronic Transcript Accumulation ................................................. 129
iii. Total Mitochondrial Transcripts ............................................................ 131
iv. ROS Assay ............................................................................................. 132

11

List of Tables and Figures
Figure 1A: Protein Motifs of PNPase ............................................................................................ 20
Figure 1B: Structure of PNPase .................................................................................................... 20
Figure 2: Localization of PNPase in the Mitochondria ................................................................. 22
Figure 3: Roles and Subcellular Localization of PNPase .............................................................. 25
Figure 4: Wildtype vs Mutant PNPase .......................................................................................... 29
Figure 5: Anatomy of C. elegans hermaphrodite body ................................................................ 31
Figure 6A: Development of the C. elegans germline .................................................................... 34
Figure 6B: Genes involved in Gametogenesis .............................................................................. 35
Figure 7: Effects of gld-1 mutants ................................................................................................. 37
Table 1: General PCR Protocol Outline ........................................................................................ 43
Table 2: Standard qPCR Reaction (15 uL) and Reagent Components .......................................... 44
Table 3: qPCR Experiments and cDNA Dilutions ........................................................................ 44
Figure 8: 2X Backcross Mechanism for Mutant Strains ............................................................... 48
Table 4: PCR and Digest Protocol for Mutation Genotyping ........................................................ 49
Figure 9: Outline of PCR Fusion Plan ........................................................................................... 52
Table 5: Primer, Template, Annealing Temperature, and Product Size of Step 1 ........................ 53
Table 6: Step 1 PCR Protocol for PCR Fusion .............................................................................. 53
Table 7: Template, Annealing Temperature, and Product Size of Step 2A ................................. 54
Table 8: Step 2A PCR Protocol for PCR Fusion ......................................................................... 54
Table 9: Primer, Template, Annealing Temperature, and Product Size of Step 2B .................... 55
Table 10: Step 2B PCR Protocol for PCR Fusion ....................................................................... 55
Table 11: Template, Annealing Temperature, and Product Size of Step 3A................................ 56

12
Table 12: Step 3A PCR Protocol for PCR Fusion ....................................................................... 56
Table 13: Primer, Template, Annealing Temperature, and Product Size for Step 3B ................. 57
Table 14: Step 3B PCR Protocol for PCR Fusion ....................................................................... 57
Table 15: Parameters and Conditions for Antibodies .................................................................. 61
Table 16: Primary and Secondary Antibody List and Associated Description ........................... 65
Table 17: Double Staining Protocol for FLAG-Tag and K76 ..................................................... 65
Table 18: Primer List ................................................................................................................... 67
Table 19: Primer Annealing Temperature ................................................................................... 70
Table 20: Mutant strains available for pnpt-1 .............................................................................. 74
Figure 10: PNPase Expression in Mutant Strains ....................... ................................................ 75
Figure 11: Mitochondrial DNA Gene Map of C. Elegans ........................................................... 77
Figure 12: Polycistronic Transcript Accumulation ...................................................................... 77
Figure 13: Total Mitochondrial Transcripts measured by qRT-PCR .......................................... 78
Figure 14: ROS production in Mutant Strains ............................................................................. 80
Figure 15: Adult and young adult transgenic C. elegans ............................................................. 82
Table 21: pnpt-1 Transgenic lines ................................................................................................ 82
Figure 16: Exogenous PNPase Expression Under Two Heat Shock Protocols ........................... 84
Figure 17: FLAG Tag Expression in Transgenic Lines ............................................................... 85
Figure 18: Total pnpt-1 Expression in Heat Shocked Transgenic lines ....................................... 87
Figure 19: Exogenous PNPase Expression .................................................................................. 88
Figure 20: Polycistronic transcript accumulation in Heat Shocked Transgenic Lines ................ 89
Figure 21: Total Mitochondrial Transcripts in Heat Shocked Transgenic Lines ......................... 90
Figure 22: ROS production in Heat Shocked transgenic lines .................................................... 91

13

Figure 23: Exogenous PNPase Expression in Heat Shocked CF3152 FSN 3B3 strain .............. 93
Figure 24: Oocyte Production in Heat Shocked Animals ............................................................ 94
Figure 25: Oocyte Development of gld-1 KD CF3152 Control Worms ..................................... 96
Figure 26: Oocyte Development of gld-1 KD CF3152 with Heat Shock .................................... 97
Figure 27: Oocyte Development of gld-1 KD CF3152 pPD 3A1 no Heat Shock ....................... 98
Figure 28: Oocyte Development gld-1 KD CF3152 pPD 3A1 with Heat Shock ........................ 99
Figure 29: Gonad of gld-1 KD CF3152 FSN 3B3 Without Heat Shock ................................... 100
Figure 30: Gonad of gld-1 KD CF3152 FSN 3B3 with Heat Shock ......................................... 101
Figure 31: pnpt-1 expression of Knockdown Samples .............................................................. 129
Figure 32: PNPase Expression in Knockdown Samples a, d, f ................................................. 130
Figure 33: Knockdown of PNPase ..............................................................................................131
Figure 34: Total Mitochondrial Transcripts in Knockdown Animals ....................................... 132
Figure 35: PNPase expression in RNAi strains associated with ROS Assay .............................132
Figure 36: ROS Production in Knockdown Animals .................................................................133
Figure 37: Total PNPase Expression of all 3 expression profiles of PNPase ............................ 134
Figure 38: Polycistronic Transcript Accumulation from all 3 expression profiles of PNPase .. 135
Figure 39: Total Mitochondrial Transcripts from all 3 expression profiles ............................... 136
Figure 40: ROS Assay for all 3 expression profiles of PNPase ................................................. 137

14
List of Abbreviations
CDC 25.1 – Cell division cycle 25.1
CDKI p27KIP1 – Cyclin-dependent kinases 1 (tumor) protein 27 kinase inhibitory protein 1
cDNA – Complementary DNA
CGC – Caenorhabditis Genetics Center
c-myc – Cellular- MYC protooncogene
COIII – Cytochrome c oxidase subunit 3
CRISPR – Clustered regularly interspaced short palindromic repeats
CTB-1 – Cytochrome B – 1
DIC – Differential interference contrast microscopy
DNA – Deoxyribonucleic acid
dsRNA – Double stranded RNA
EMS – Ethyl methanesulfonate
ENU – N-ethyl-N-nitrosourea
FBF-1/2 – fem-3 Binding factor 1 / 2
FSN PCR – Fusion PCR
FZR-1 – Fizzy and cell division cycle 20 related 1
GLD-1 – Germ line development 1
GLD-2 – Germline development 2
hsp – Heat shock protein
IFN – Interferon
IPTG – Isopropyl beta-d-1-thiogalactopyranoside
KH – K homology

15

LB – Liquid broth
LIN-35 – Retinoblastoma-like protein homolog lin-35
MAPK – Mitogen activated protein kinase
MEX-3 – Muscle EXcess 3
miR – MicroRNA
MMP1 – Metal metallic protease 1
MPP – Mitochondrial processing peptidase
mTP – Mitochondrial targeting peptide
mtRNA – Mitochondrial RNA
MTS – Mitochondrial targeting sequence
NGM – Nematode growth media
NOS-3 – Nanos-type domain-containing protein 3
PCR – Polymerase chain reaction
PNPT1 – Polyribonucleotide nucleotidyltransferase 1
PNPase – Polynucleotide phosphorylase
qRT-PCR – Quantitative reverse transcription-PCR
RNA – Ribonucleic acid
RNAi – RNA interference
ROS – Reactive oxygen species
RPH – RNase PH
rRNA – Ribosomal RNA
SOD2 – Superoxide dismutase 2
ssRNA – Single stranded RNA

16
SW-PCR – Single worm-PCR
TIM – Translocase of the inner membrane
TOM – Translocase of the outer membrane
UNC-54 – Un-coordinated 54
UTR – Untranslated region
WLB – Worm lysis buffer
Yme-1 – Yeast mitochondrial escape 1

17

Abstract
Phenotypic Characterization of PNPase Mutation and Overexpression in C. elegans
By Brian Hur, B.S.
A thesis submitted in partial fulfillment of the requirements for the degree of Master of Science
at Virginia Commonwealth University
Virginia Commonwealth University, 2019
Major Director: Rita Shiang
Associate Professor, Department of Human and Molecular Genetics
PNPase, polynucleotide phosphorylase, is a multifunctional exoribonuclease protein with 3`
terminal oligonucleotide polymerase activity. Coded by the PNPT1 gene, the protein is
associated with mitochondrial homeostasis and functions as a possible target for cancer therapy.
In this study, C. elegans was used to investigate the effect of mutation and overexpression of
pnpt-1, the gene that encodes PNPase. It was determined that two specific mutations in pnpt-1
did not affect PNPase expression nor did they produce deleterious phenotypes that affected
polycistronic transcript accumulation or ROS production. Creation of a stable overexpression
model was achieved through Fusion PCR. However, different transgenic strains overexpressing
PNPase produced opposite results for polycistronic transcript accumulation while ROS
production saw no significant change, suggesting a mosaic overexpression model.
In a cancer model, exogenous PNPase was present in the pachytene region of the germline and
where expressed the cells were in non-germline cells suggesting differentiation mechanisms
associated with overexpression of PNPase. However, further analysis of different mutations in
pnpt-1 or optimizations to the overexpression model are necessary to provide a better
understanding of PNPase function with mitochondria homeostasis and in a cancer model setting.
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Chapter 1: Introduction
I.

PNPase
Encoded by the PNPT1 (polyribonucleotide nucleotidyltransferase 1), PNPase is an

evolutionarily conserved 3`-5` phosphate dependent exoribonuclease and 5`-3` RNA polymerase
that adds poly(A) tails to RNA molecules (Sarkar et. al., 2005; Das et. al., 2010). The protein
localizes either in the inter membrane space of the mitochondria or the cytosol (Piwowarski et.
al., 2003). In humans, the PNPT1 gene is located within 2p15-2p16.1 and spans 60 kb,
consisting of 28 exons (Leszczyniecka et. al., 2003). During a screen between terminally
differentiated HO-1 melanoma cells and senescent progeroid fibroblasts to identify co-regulated
genes, 75 genes were classified and labeled as old-1 through old-75. Among the 75 genes, old35 presented significant sequence similarity to PNPase from other species, thus cataloguing
human PNPase as hPNPase old-35 (Leszczyniecka et. al., 2002).
Functioning as an exoribonuclease, PNPase selectively degrades specific targets such as
c-myc mRNA, miR-221, miR-222, miR-106b, and other miRNAs involved in oncogenesis in the
cytosol. (Sarkar et. al., 2003; Das et. al., 2010). PNPase also regulates translocation of small
RNA molecules into the mitochondria such as MRP (mitochondria RNA processing) RNA,
RNase P, and 5S rRNA (Wang et. al., 2010). Additionally, PNPase has been found to be
induced by type I interferons, specifically IFN-alpha and beta. Studies identified an ISRE, IFNstimulated response element, in the promoter of hPNPase old-35. Mutations in this site
eliminated induction of gene expression (Leszcyzyniecka et. al., 2003).
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II.

PNPase Structure
PNPase is conserved across most organisms from simple species of bacteria to complex

and higher mammals, with the exception of yeast (Leszczyniecka et. al., 2004). The protein is
comprised of four major domains that include two RNase PH domains, one KH domain, and one
S1 domain. Spatially, the two catalytic RNase PH domains are located towards the N-terminal
end while the RNA-binding KH and S1 domains are located closer to the C-terminus (Figure 1A)
(Leszczyniecka et. al., 2004).

In humans, PNPase is a large molecule that consists of 738

amino acids with an alpha helix to separate the two RNase PH domains (Leszczyniecka et. al.,
2002). Despite the presence of conserved domains of PNPase, there are variations of the protein
structure within different organisms. PNPase in plants contains an N-terminal target peptide for
translocation of the protein to the chloroplast while the animal variant has a N-terminal
mitochondrial localization signal to direct the protein to the intermembrane space of the
mitochondria (Piwowarski et. al., 2003; Sarkar et al., 2005).
On a structural level, PNPase forms a homotrimeric structure or a dimer of homotrimers
resulting in a doughnut-like shape (Figure 1B) (Carpousis et. al., 2002). The RNase PH domains
create a channel for catalytic activity for single-stranded RNA molecules (Symmons et. al,. 2000:
Symmons et. al., 2002). Superior to the RNase PH domains are the KH and S1 domains that also
contribute to central channel structure but primarily function as RNA-binding domains
(Golzarroshan et. al.,2018). Catalytic activity from the RNase PH domains varies in different
organisms. In a review, the catalytic activity of PNPase in bacteria is primarily carried out by
the second RNase PH domain while the RNase PH domains in plants contribute equally (Sarkar
and Fisher, 2006). For human PNPase, mutational analysis has determined that both RNase PH
domains have equal catalytic activity and the presence of at least one RNase PH domain is
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adequate for complete enzymatic activity (Sarkar et. al., 2005). The KH and S1 domains are also
vital to protein function. Deletion of the S1 or KH domains results in a decrease in enzymatic
activity by 50 fold and 19 fold, respectively, while deletion of both domains results in 1% of
enzymatic activity (Stickney et. al., 2005)

Figure 1A: Protein motifs of PNPase. Both RNase PH, KH, and S1 domains are conserved
across several organisms. PNPase in different organisms contain variations in the N-terminal
targeting sequence/peptide or no targeting sequence/peptide at all. (Sohki et. al., 2013)

Figure 1B: Structure of PNPase. PNPase assembles into a homotrimer revealing a donut-like
structure with a channel in the middle where catalytic activity takes place. (Shi et. al., 2008)
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III.

PNPase Localization
Human PNPase is mainly localized within the intermembrane space of the mitochondria

(Piwowarski et. al., 2003). The N-terminal mitochondrial targeting sequence (MTS) of the
protein directs it to the organelle (Chen et. al., 2006). PNPase is then imported through the TOM
and TIM23 pores of the mitochondria where it is cleaved by MPP (mitochondrial processing
peptidase) at the region following the N-terminal targeting sequence. Yme1 serves as a
translocation motor that pulls PNPase into the intermembrane space where PNPase assembles
into the final multimeric complex (Figure 2) (Rainey et. al., 2006). Cleavage of the N-terminal
targeting sequence by MPP exposes a hydrophobic region on PNPase that is hypothesized to
serve as a stop-transfer domain to stop translocation through TIM23 (Rainey et. al., 2006).
Depending on the organism, PNPase localizes in different regions. In plants, PNPase
localizes in the chloroplast stroma and functions as a poly(A) polymerase and exoribonuclease
(Chen et. al., 2006). Outside of plants and in multiple cell types, PNPase is found in the
intermembrane space of the mitochondria, regulating mtRNA levels (Chen et. al., 2006;
Piwowarski et. al., 2003). Other studies have also noted that hPNPase can localize in the
cytoplasm where it degrades specific mRNA and miRNA molecules. (Leszczyniecka et. al.,
2002; Sarker et. al., 2003; Das et. al., 2010).
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Figure 2: Localization of PNPase in the mitochondria. Mechanism of PNPase localization in
the intermembrane space of the mitochondria through the Yme1 complex and MPP. (Rainey et.
al., 2006)
IV.

Functional Studies – Mouse Knockout and Cellular Knockdown
Previous in vivo mouse studies had attempted knocking out PNPase but were

unsuccessful since it was determined that embryos without PNPase were nonviable and
embryonic lethal (Wang et. al., 2010). Instead, a conditional liver knockout of PNPase was
produced in a mouse model. Knockout of PNPase in liver cells resulted in disrupted respiration
and mitochondrial morphology with mitochondria cristae appearing disordered, circular, and
smooth (Wang et. al., 2010). Inhibition of mitochondrial RNA transport which regulate the
transcription and translation of electron transport chain proteins partially contributed to the
disrupted respiration mechanisms (Wang et. al., 2010).
PNPase knockdown was also performed in melanoma cell line HEK-293T (Chen et. al.,
2006). Results included impairment of the respiratory chain complex with a decrease in
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enzymatic activity, mitochondria appearing filamentous and granular, and decrease in complex 3
and 4 potential of the respiratory chain complex (Chen et. al., 2006). All of this contributed to a
decrease in cell growth with increased cell death (Chen et. al, 2006).
V.

Functional Studies – Cellular Overexpression
Overexpression of hPNPase old-35 was studied in HO-1 cells with two different

approaches to analyze growth suppression mechanisms: slow and sustained overexpression with
low multiplicity of adenoviral vector and rapid overexpression with a high multiplicity of an
adenoviral vector (Sarkar et. al., 2003). Each overexpression mechanism produced different
results. Slow and sustained overexpression resulted in an induction of a senescent-like
phenotype and growth inhibition (Sarkar et. al., 2003). Infected HO-1 cells arrested in the G1
phase of the cell cycle with a reduction of cells in the S phase that eventually lead to apoptosis
(Sarkar et. al., 2003; van Maerken et. al., 2009). Rapid overexpression of PNPase resulted in
induced growth arrest and promotion of apoptosis without any changes to the cell cycle (Sarkar
et. al., 2003).
Overexpression of PNPase also decreased expression of c-myc mRNA and Myc protein,
a transcription factor that regulates cell growth (Sarkar et. al., 2003). hPNPase old-35 selectively
degraded c-myc RNA molecules through recognition of the 3` UTR, which led to blocked
mitogenic signals and cells driven to terminal differentiation (Sarkar et. al., 2003; Sarkar et al
2006). Other effects of overexpressing hPNPase included inhibition of DNA synthesis and
telomerase activity, and up regulation of CDKI p27KIP1 (Sarkar et. al., 2005). All of these
factors contributed to the senescent-like phenotype associated with overexpression of hPNPase
old-35 (Sarkar et. al., 2003; Sarkar et. al., 2005).
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Overexpressed hPNPase old-35 also targets and degrades other RNA molecules such as
miR-221, miR-222, and miR-106b (Das et. al., 2009). miR-221 is often upregulated in various
human cancers including glioblastoma, liver, bladder, thyroid, pancreatic, gastric and prostate
carcinomas (Lupini et. al., 2013). miR-222 is also upregulated in several cancer types, targeting
MMP1 (metal metallic protease 1) and SOD2 (superoxide dismutase 2) (Liu et. al., 2009). miR106b targets several tumor suppressor genes (Liu et. al., 2014). In a comparison with normal
cells, tumorigenic cells presented down-regulated expression of hPNPase old-35, allowing
upregulation of oncogenic miRNA molecules to facilitate tumorigenesis (Das et. al., 2009). The
correlation between miRNA targets of hPNPase and cancer progression makes overexpression of
hPNPase old-35 an appealing anti-cancer approach.
VI.

PNPase in the Mitochondria
Due to the localization of hPNPase old-35 in the intermembrane space of the

mitochondria, several studies investigated if hPNPase-old 35 has a role in mitochondrial
homeostasis. Overexpressing hPNPase old-35 resulted in an increase in reactive oxygen specie
(ROS) production (Sarkar et. al., 2004). Increase in ROS production led to an increased
activation of the NF-kB pathway and the downstream genes associated with proinflammatory
cytokine synthesis (Sarkar et. al., 2004). Ultimately, overexpression of hPNPase old-35 induced
a senescent-like growth arrest phenotype with increased production of ROS contributing to
irreversible growth arrest of the cell (Sarkar et. al., 2004). Knockdown studies in HEK293T
cells that decreased expression of hPNPase old-35 resulted in mitochondrial dysfunction (Chen
et. al., 2006). Mitochondria appeared to be fragmented, filamentous, and granular shaped with
decreased membrane potential (Chen et. al., 2006). At the enzymatic level, coupled respiratory
complexes I/III, and II/III presented reduced enzymatic activity with dysfunction in complex I of
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the electron transport chain, resulting in elevated lactate and decreased ATP levels (Chen et. al.,
2006).
hPNPase old-35 also functions as an importer trafficking small RNA molecules into the
mitochondria, specifically RNase P RNA, MRP RNA, and 5S RNA (Wang et. al., 2012). RNase
P is an endoribonuclease that processes mitochondrial tRNAs. MRP RNA is a site-specific
endonuclease that processes mtRNA transcripts to form primers to initiate replication of mtDNA.
5S rRNA is a ribosomal component that provides regulatory interactions among the functional
sites of the translating protein (Wang et. al., 2012). The figure below displays the various roles
PNPase plays within the cell at different locations (Figure 3).

Figure 3: Roles and subcellular localization of PNPase. PNPase in the cytoplasm functions in
miRNA and c-myc degradation. Upon entry into the mitochondria through the TOM/TIM
complex, PNPase mechanisms associate with ROS production, mtRNA processing, RNA
polymerization, and RNA import into the organelle. (Sohki et. al., 2013)
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VII.

Human Diseases

In a clinical setting, mutations in PNPase have been associated with myopathy,
encephalopathy, and neuropathy (Vedrenne et. al., 2012) and human hereditary hearing loss (von
Ameln et. al., 2012). These studies highlight PNPase’s connection with mitochondrial function
and homeostasis. In the first study, two siblings of consanguineous parents presented with a
homozygous missense mutation in the second RNase PH catalytic domain of PNPT1 (c. 1160
A>G)(Q387R). In the first child, there was a significant decrease in 5S rRNA and MRP RNA
import into the mitochondria and decreased rate of mitochondrial translation. The child had slow
voluntary movements, dystonia, dyskinesia, choreoathetosis, global hypotonia, severe muscle
weakness, and no head control. Due to muscle atrophy, deep tendon reflexes were barely
detected. The second child developed motor regression with trunk hypotonia, choreoathetotic
movements, major dystonia in the limbs, and global hypotonia. Overall, the two children had
fixed but nonprogressive encephalopathy with mildly elevated levels of lactate in the plasma and
cerebrospinal fluid. On a molecular level, there was decreased activity of respiratory chain
complexes III and IV in the liver in the first child. The second child presented normal enzymatic
activity in both skeletal muscle samples and cultured skin fibroblasts (Vedrenne et. al., 2012).
The results above provided strong evidence of the role of PNPase in RNA import into the
mitochondria and maintenance of a functional respiratory chain complex (Vedrenne et. al.,
2012).
The second study consisted of 3 siblings from a consanguineous family that presented
with severe hearing impairment. Sequence analysis identified a missense mutation in the second
RNase PH catalytic PNPT1 (c. 1424 A>G)(E475G) in the second RNase-PH domain. The
missense mutation interfered with oligomerization and prevented PNPase from properly forming
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a homotrimer, but the protein was able to behave as a hypomorph. Trimerization was reduced
with increased monomer formation that had decreased protein function. As a result, a decrease
of RNase P RNA import into the mitochondria was observed. Due to the high energy demand of
the inner ear, it was hypothesized that the slower rate of import of small RNA molecules of the
PNPase hypomorph negatively affected the inner ear tissue and not others. Variation of
phenotypes observed between the two families led researchers to hypothesize that the different
functional deficits of PNPase was dependent on the severity of the mutation (von Ameln et. al.,
2012).
A third human study identified two siblings from a non-consanguineous family that
presented disease phenotypes which included severe axonal neuropathy, optic atrophy,
intellectual disability, auditory neuropathy and chronic respiratory and gut disturbances (Alodaib
et. al., 2016). Unlike the previous studies, whole exome sequencing on all family members
identified compound heterozygous missense variants in the PNPT1 gene in the two affected
siblings with mutations Q254K in the first catalytic RNase PH domain and A510P in the second
RNase PH domain that were predicted to be damaging (Alodaib et. al., 2016). In patient
fibroblasts, the missense mutations affected quaternary formation of PNPase protein and
presented a reduction in protein and mRNA expression of PNPT1 when compared to samples
from unaffected family members. However, mRNA expression of PNPT1 did not vary in blood
samples from unaffected and affected family members. Analysis of the oxidative
phosphorylation complexes identified significant reduction of expression with complex I, III, and
IV and decreased enzymatic activity of complex I and IV in the patient fibroblasts. The study
also confirmed impairment of mitochondrial translation with a 33% reduction in total
mitochondrial protein synthesis in comparison to the unaffected control (Alodaib et. al., 2016).
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Another study observed the effects of the disease-causing missense mutations, Q387R
and E475G, in the second RNase PH catalytic domain of PNPase on a proteomic and molecular
level using Escherichia coli. As a result of the mutations, PNPase formed dimers rather than
trimers and had significantly lower RNA binding and degradation activities compared to wildtype trimeric PNPase (Golzarroshan et. al., 2018). Specifically, human PNPase mutants formed
a dimeric structure with a disrupted KH pore that impeded ssRNA binding. Analysis of the KH
pore in trimeric PNPase identified exposed GXXG motifs within the KH domain oriented inward
toward the pore. This positioning of GXXG motifs facilitated interactions with and binding to
ssRNA (Golzarroshan et. al., 2018). However, the dimeric mutant PNPase presented a disrupted
KH pore with GXXG motifs located far apart, making them less available for RNA binding and
interaction (Figure 4). These findings explained the decreased ssRNA binding and degrading
activity in mutant dimeric PNPase compared to trimeric PNPase (Golzarroshan et. al., 2018).
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Figure 4: Wildtype vs Mutant PNPase. (A) Wildtype PNPase trimer forms a donut-like shape
with GXXG motifs of KH domains located close to each to other at the KH pore. (B) Mutant
PNPase that resulted in a dimeric protein with KH domains distant from each other.
(Golzarroshan et al., 2018)
VIII. ROS
ROS, products of cellular respiration, are synthesized when molecular oxygen (O2) is
reduced. Such species include hydrogen peroxide, hydroxyl radical, and superoxide. Within the
mitochondrial electron transport chain, Complex I and Complex III are responsible for the
synthesis and release of superoxides into the intermembrane space of the mitochondria. Sizeable
accumulations of ROS within the cell damages proteins, lipids, and DNA. However, low
amounts of ROS molecules can serve as activators for signaling pathways associated with

30
proliferation and transcription (Trachootham et. al., 2008; Droge et. al., 2002; Thannickal et. al.,
2000). Studies have proven that slight increases in ROS activate beneficial stress responses that
lead to lifespan extension rather than producing harmful effects (Zarse et. al., 2012; Schulz et.
al., 2007). To offset the accumulation and effect of superoxides, superoxide dismutase converts
superoxide into hydrogen peroxide. The hydrogen peroxide is then eliminated by other
peroxiredoxins and peroxidases (Sena and Chandel, 2012).
IX.

C. elegans
Caenorhabditis elegans is a free living nematode that is used as a popular model

organism for studies of developmental biology and basic functions and mechanisms of
eukaryotic cells (Corsi et. al., 2015). Championed by Syndey Brenner, this specific nematode
species proves to be a valuable model to study mutations that contribute to human diseases. The
animal exists mostly as self-fertilizing hermaphrodites with a genotype of XX for sex
chromosomes. Male C. elegans are present but arise at a low frequency of <0.2% with a XO
genotype (Corsi et. al., 2015). Their self-fertilizing nature allows stocks to be maintained from a
single animal, giving rise to an entire population.
C. elegans is an attractive model due to a short three day life cycle to develop from an
egg to a 1 millimeter long egg-laying adult, small size, complete sequenced genome, and ease of
growth and maintenance. Their transparent body throughout their life cycle allows easy
examination of cells with differential interference contrast (DIC) microscopy (Corsi et. al.,
2015). Due to their simple nature, the nematode is an optimal system to investigate the genetics
of basic behavior mechanisms such as foraging, feeding, defecation, movement, egg laying,
sensory responses to touch, smell, and other simple forms of behavior (Rankin et. al., 2002).
However, there are limitations that prevent C. elegans from being the perfect model organism.
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Such as lacking specialized tissues found in higher organisms (Van Raamsdonk and Hekimi,
2010).

Figure 5: Anatomy of C. elegans hermaphrodite body
(https://en.wikipedia.org/wiki/Caenorhabditis_elegans#/media/File:Caenorhabditis_elegans_her
maphrodite_adult-en.svg)
X.

PNPase in C. elegans
In C. elegans, the ortholog for PNPT1 is pnpt-1 and consists of 10 exons located on

chromosome III. The pnpt-1 transcript was initially identified during an RNA interference
(RNAi) profiling of embryogenesis (Sonnichsen et. al., 2005). tm1909, a deletion mutant,
resulted in lethal and sterile phenotypes. However, this deletion mutant was not limited to pnpt1 and included a neighboring upstream gene, chin-1.
C. elegans proved to be the ideal model for this project due to ease of gene expression
manipulation through RNAi, a molecular process where dsRNA inhibits gene expression or
translation, for knockdown analysis, ectopic expression through transgenic overexpression
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analysis, the availability of mutant strains from the Caenorhabditis Genetics Center (CGC) for
mutant analysis, and the ease and varied approaches at producing a cancer model. Since
previous attempts to produce a knockout model in other organisms were met with little success
due to embryonic lethality (Wang et. al., 2010), and with no documentation of an overexpression
animal model present, using C. elegans will provide a foundational understanding of the
phenotypic effects of varied PNPase expression and observation of the senescent induced
phenotype associated with overexpression of PNPase in a cancer model setting.
XI.

C. elegans Germline
Germline development of C. elegans can be organized into three distinct phases:

specification, growth, and maintenance (Figure 5A). During early embryogenesis, P blastomeres
are distinguished from somatic cells with the germline founder cell, P4, giving rise to only germ
cells with no contribution to the soma. P granules are segregated into the P blastomeres,
contributing to germline development. During the hatching stages of the nematode, the gonad
consists to two primordial germ cells, Z2 and Z3, flanked by two somatic gonad precursors, Z1
and Z4. During the first two larval stages, the somatic gonad precursors divide to initially
produce 12 cells, ten of which rearrange into somatic gonad primordium while the other two
form the distal tip cells. During the L3 stage, both gonad arms extend concurrently with
proliferation of the germ line. The L4 stage is identified by four-fold growth of germ cell
number with germ cell proliferation in the distal mitotic zone (Hubbard et. al., 2005). Entry from
the mitotic zone into meiotic division at the proximal end of the gonad requires coordination of
GLD-1, GLD-2, FBF-1/2, and NOS-3 signaling (Figure 5B) (Nayak et. al., 2004). Within the
transition zone between the mitotic and meiotic zones, chromosomes pair and undergo meiotic
recombination until the pachytene stage. Upon entry into the meiotic zone, homologous
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recombination and formation of synaptonemal complexes occur with germ cell chromosomes.
Mitogen activated protein kinase (MAPK) signaling in the germline allows progression from
pachytene to diplotene. From diplotene to diakineses, meiotic chromosomes become highly
condensed and form six discrete oocyte bivalents (Hubbard et. al., 2005).
Gametogenesis varies depending on the age of the nematode. The late L4 stage is
marked by spermatogenesis while the adult stage is marked by oogenesis (Hubbard et. al., 2005).
During L4, GLD-1 and FOG-2 work together to inhibit tra-2 activity allowing fem-3 to be active
and promote spermatogenesis. When entering the adult stage, gld-1 and fog-2 are inactive,
increasing tra-2 activity that causes repression of fem-3 function and switching the germline to
oogenesis (Figure 5B) (Nayak et. al., 2004). Ultimately, gonads of hermaphroditic C. elegans
consist of a linear sequence of germ cells in different developmental stages (Ciosk et. al., 2006).
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Figure 6A: Development of the C. elegans germline. (A). Development of the germline
founder cell (P4) and its associated primordial germ cells, Z2 and Z3, from the zygote stage of
the nematode. (B). Gonad formation and growth at different stages of nematode development.
Red cells represent the distal tip cells. Yellow represents the mitotic region. Light green
represents the transition phase consisting of early prophase of meiosis I. Dark green represents
pachytene. Pink represents oogenesis. Blue sheath represents the spermatheca precursor cells.
Light blue sheath represents nuclei. Grey represents the spermatheca. White represents the
uterus. (Hubbard et. al., 2005)
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Figure 6B: Genes involved in gametogenesis. (a) Interactions between several factors that
regulate the switch between spermatogenesis and oogenesis. (b) Schematic of fog-2 and gld-1
inhibition on tra-2 mRNA, allowing spermatogenesis. (Nayak et. al., 2004)
XII.

gld-1 Cancer Model in C. elegans

Several factors allow C. elegans to be useful for cancer research. The model is
completely characterized with an invariant somatic cell lineage allowing ease of identification of
phenotypes that disrupt normal proliferation and patterning (Sulston and Horvitz, 1977; Sulston
et. al., 1983). The animal’s transparent body throughout its entire lifespan allows cells to be
visualized during their division and movement. Finally, many human genes and pathways
associated with cancer are conserved in C. elegans (Kirienko et. al., 2014). While the pathways
and mechanisms are complex in a human setting, regulatory networks related to cancer in
C. elegans are simplified with fewer genes involved (Hunter and Pines, 1994).
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For our cancer model, gld-1 knockdown in the nematode germline was used to create an
over proliferation and tumor phenotype. Under normal conditions, GLD-1, an RNA binding
protein, functions as a germline specific tumor suppressor that is responsible for the transition
from spermatogenesis to oogenesis (Nayak et. al., 2004). The protein regulates the transition
between mitotic division in the distal end to meiotic division at the proximal end of the gonad
(Ciosk et. al., 2006). GLD-1 expression is inhibited in the distal mitotic zone (Crittenden et. al.,
2002) but is observed to have higher levels of expression in the central region of the gonad
(Jones et. al., 1996). With loss of function mutations of gld-1, tumors develop from germ cells
that initiate meiosis but return to mitosis prior to completion of meiotic prophase (Figure 6A and
6B) (Francis et al., 1995). In addition to mass mitotic division, one study has identified nuclei in
the germline resembling nuclei found in somatic tissues upon knockdown of gld-1 but saw
higher incidence of these nuclei in gld-1 and mex-3 knockdown (Ciosk et. al., 2006). Further
analysis has determined the non-germline cells were differentiated somatic cells such as muscle
cells, neurons, and intestinal cells (Ciosk et. al., 2006). Using gld-1 knockdown as a cancer
model in the germline will allow observation of the effects of overexpression of ectopic PNPase
during tumor development in a whole animal model setting.
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Figure 7: Effects of gld-1 mutants. Mutation in gld-1 produces a tumor-like phenotype with
mass proliferation of mitotically dividing cells present in the proximal region of the gonad where
meiotic division normally takes place. (Kirienko et. al., 2014)

XIII. Preliminary Studies of PNPase Knockdown in C. elegans
Previous work has studied the phenotypic effect of PNPase knockdown in C. elegans.
Knockdown was achieved through feeding RNAi using an RNAi clone that produced dsRNA
corresponding to pnpt-1. The clone consisted of a 558 base pair region 5` of exon 1 to exon 3 of
wPNPase. The study determined that decrease in PNPase expression caused an increase in
lifespan due to increased ROS production. Additionally, decreased PNPase expression
contributed to an altered fission/fusion ratio of the mitochondria but with no presentation of
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disordered cristae. The lack of disordered cristae could be contributed to actions of other
pathways and recovery mechanisms (Lambert 2015).
XIV. Project Outline
The main goal of this project is to generate animal models for pnpt-1 (mutant and
overexpression) in C. elegans to analyze their effect on mitochondrial homeostasis and induction
of cellular senescence in a cancer model. To carry out this plan, mutant and overexpression
models were produced and tested for downstream phenotypes including testing the effects of
pnpt-1 overexpression in a gld-1 nematode cancer model to determine if it ameliorates aberrant
proliferating cells. Strains that contain mutations in wpnpt-1 will be obtained from the CGC and
backcrossed to generate a background removed of unlinked mutations. Production of transgenic
lines for an overexpression model of PNPase will first require synthesis of the ectopic construct.
Fusion PCR will be used to create the construct under a heat-inducible promoter and it will be
introduced into C. elegans by microinjection. Protocols to induce expression will be optimized
to activate exogenous PNPase expression. Knockdown of PNPase will be achieved by RNAi
mechanisms, following a similar protocol adopted by previous work (Lambert 2015). Once all
three models have be created and optimized, polycistronic transcripts and total mitochondrial
transcripts will be quantified, and ROS levels will be measured. A tumorous phenotype will be
achieved using the gld-1 cancer model to produce a proliferating tumor phenotype.
Immunofluorescence will be used to analyze germline cells in the nematode gonad and will
determine the senescent-inducing and differentiating role of PNPase overexpression.
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Chapter 2: Materials and Methods

OP50 Liquid Cultures/Seeding NGM plates
Nematodes were fed OP50 bacterial cultures for regular maintenance. Bacteria from
glycerol stocks of OP50 was streaked for isolation on LB plates. Individual bacterial colonies
were picked with a P200 pipette tip and placed in 3 mLs of LB liquid media. Liquid cultures
were incubated overnight at 37°C and 225 rpm. Approximately 150 uL of OP50 liquid culture
was used to seed each medium (60mm x 15 mm) NGM (nematode growth media) plate. The 150
uL solution was distributed among 5 individual dots on the plate surface. Seeded plates were
incubated overnight at 37°C and then placed in 4°C for long term storage.

C. elegans Maintenance
C. elegans were grown on NGM and fed OP50 bacteria and maintained at 20°C. Plates
were individually parafilmed to prevent contamination. All worm strains were regularly
maintained by either chunk transferring once a week or transferring 5-10 adult hermaphrodites
every 4 days.

C. elegans Strains
For RNAi experiments, mutant strain CF3152 [rrf-3 (pk1426)] was obtained from Dr.
Malene Hanson. Mutant studies consisted of strains containing point mutations in pnpt-1:G58E
(VC40327), G74R (VC20261), and G74E (VC20284). VC2010, a N2 wildtype derivative, was
used as a control for mutant studies. These strain were obtained from the CGC and were
generated as part of the million mutation project (Thompson et. al., 2013).
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Frozen Stocks of Worms
Plates of recently starved L1/L2 hermaphrodites were washed with 0.6 mLs S Buffer
(64.5 mM K2HPO4, 43.55 mM KH2PO4, 0.1 M NaCl) and transferred to cryotubes. Equal
volumes of S Buffer + 30% glycerin (sterile) were added to a crytotube and vortexed to mix
contents well. Samples were stored in -80°C freezer.
To reconstitute a worm line, cryotubes were thawed at room temperature and gently
vortexed to mix contents. Half a milliliter of solution was pipetted onto OP50 seeded NGM
plate. Plates were parafilmed and stored at 20°C for worms to develop.

RNAi Bacterial Strains
RNAi was induced through feeding the worms bacteria expressing dsRNA. Liquid
bacterial cultures were initially grown overnight in LB with ampicillin (100 ng/uL) at 225 rpm at
37°C. Overnight cultures were diluted 1:100 in fresh LB with ampicillin (100 ng/uL). Cultures
were then incubated in a shaker at 225 rpm and 37°C for 3 hours. IPTG was added (0.4 mM)
with additional ampicillin (100 ng/uL). Samples were returned to the 37°C shaker for 2 hours.
Ampicillin (100 ng/uL) and IPTG (0.4 mM) were added one last time. Plates were seeded with
200 uL of culture per 6 cm NGM + carbenicillin (0.1 mg/mL) plate (Lambert 2015).
Bacterial strains for RNAi were Exon 3 for knockdown of wpnpt-1 (Lambert 2015),
L4440 for empty vector control, T74 B4-7 for dpy10, a positive control that produced the
“dumpy” phenotype (Dr. Jill Bettinger), and 1-F308 for gld-1 (Dr. Malene Hansen) knockdown
to produce the overgrowth phenotype in the cancer model studies. Strain Exon 3 was
synthesized in our lab by Laura Lambert.
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RNAi induced strains were plated with seven L4 hermaphroditic CF3152 worms per
plate. L4 hermaphrodites were allowed to lay eggs overnight and removed to produced age
matched progeny after 4 days of development. For RNA extraction, L4 CF3152 hermaphrodites
were not removed after overnight egg laying but were allowed to continuously lay eggs.

Extracting DNA from C. elegans
Ten to twenty adult worms were picked and dropped into 20 uL of worm lysis buffer
(WLB) (10mM Tris (pH 8.0), 50 mM KCl, 2.5 mM MgCl2, 0.45% Tween 20, 0.45% NP-40, and
0.05% Gelatin) with freshly added Proteinase K at a final concentration of 60 ng/uL. The worm
and buffer mixture was frozen at -80°C for at least 30 min. Samples were then incubated in a
65°C water bath for 60 minutes. Samples were then incubated at 95°C for 15 min to inactivate
the Proteinase K. DNA was stored at -20°C. For single worm PCR (SW-PCR), only one adult
worm was picked and dropped into 20 uL of WLB with Proteinase K. All subsequent steps
remained the same.

Extracting RNA from C. elegans
For mutant and transgenic lines, ten L4 hermaphrodites were transferred to fresh OP50
seeded NGM plates. Five 60 mm x 15 mm plates were used for each line. For RNAi samples,
seven L4 CF3152 hermaphrodites were transferred to RNAi carbenicillin plates. Seven 60mm x
15mm plates were used for each RNAi induced sample. Progeny were allowed to develop for
four days at 20°C prior to extracting RNA. Worms were washed off with 1 mL of M9 twice and
transferred to a 15 mL conical tube. Worms were pelleted at 1000 rpm for 5 min and the
supernatant was discarded. Worms were washed 3 more times with 5 mLs of M9. After the
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supernatant was removed after the final wash, 200 uL Trizol reagent (Ambion 15596026) was
added. Worms in Trizol were frozen at -80°C for at least 30 minutes. Worms were then freezecracked: alternating 20 seconds in liquid nitrogen followed by 1 minute thaw in 37°C water bath
and repeated 10 times. The trizol/worm mixture was transferred to 1.5 mL tube and 200 uL of
chloroform was added. The sample was spun at 13,000 rpm at 4°C for 15 min. The aqueous
fraction was transferred to a new 1.5 mL tube. An equal volume of 70% isopropanol was added
to the aqueous fraction. The Qiagen RNeasy Mini Kit was used for subsequent steps of RNA
isolation following manufacturer’s instructions. RNA samples were stored at -80°C.
RNA samples were DNase treated using the RQ1 RNase-Free DNase Kit (Promega) to
remove DNA contamination. One Unit per ug RNA of RQ1 RNase-Free DNase, and RQ1
RNase-Free DNase 10X buffer to bring the final concentration of buffer to 1X was added to the
RNA. The sample was incubated at 37°C for 30 minutes. RQ1 DNase Stop Solution was added
(same volume as 10X buffer) and samples were incubated at 65°C for 10 minutes to inactivate
the DNase. DNase treated RNA samples were stored in -80°C.

Generating cDNA
The following reagents were added in a 0.65 mL tube: 0.5 ug RNA, 100 ng oligo dT
primer, 100 ng random primer, and DEPC H20 to 12 uL. Samples were incubated at 70°C for 10
minutes. A mix of 1X MMLV RT buffer, 10 mM DTT, 1 mM dNTPs, 10 units RNasin
(Promega), and 100 units of MMLV RT (Promega) was added. Samples were incubated at 37oC
for 1 hour followed by incubation at 95°C for 5 minutes. cDNA was used for downstream
applications or stored at -20°C.
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PCR
PCR was performed to obtain annealing conditions for qPCR, optimizing cloning
primers, to genotype worms for backcrosses, to create the transgenic pnpt-1 clone by traditional
cloning methods and Gibson assembly, and to produce fragments for sequencing analysis. Phire
Hot Start II DNA Polymerase Kit (Thermo Fisher Scientific F122S) and its corresponding 5X
buffer was used for all PCR reactions. The list of primers used in PCR reactions are listed below
along with their annealing conditions (Table 18 and 19). PCR reaction components are found in
Table 1 and cycling parameters were:
1.5’ 94°C – [30” 94°C – 30” annealing temperature – 30” 72°C] x30 – 7’ 72°C.
Reagents
DNA
5X Phire II Buffer
Phire Hot Start II DNA
Polymerase
Primers
dNTPs
Water (Hyclone Water)

Final Concentration
X uL
1X
0.05 – 0.08 uL

Manufacturer
N/A
Thermo Fisher Scientific F122S
Thermo Fisher Scientific F122S
IDT
Bioline
GE

0.5 uM
2mM
Bring to final reaction
volume
Table 1: General PCR Protocol Outline: List of reagents and their final concentrations for a
PCR protocol * For backcross genotyping PCR protocol, see Table 4 ** For Fusion PCR
experiments, see Tables 8, 10, 12, and 14.
qPCR
qPCRs were all performed at 60o C annealing temperatures under standard reaction
conditions (Table 2). iTaq Universal SYBR Green Supermix (Bio-Rad) was used with primers
at a final concentration of 0.94 uM and diluted cDNA in a 15 uL single reaction. Reactions were
run in triplicate in a 96 well plate. Control cDNA was used to determine ideal cDNA dilutions
for each experiment (Table 3). Fold changes were determined from cT, dCT, and ddCT values
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when comparing cT values between control and sample of interest. dCT values were determine
by: dCT = cT'() − cT+,-./ with GOI = gene of interest. ddCT values were determined by :
ddCT = dCT − dCT,1/-213 . Fold change was determined by: Fold Change = 2=>>?- .
Controls for heat shocked transgenic line strains were non-heat shocked transgenic lines.
Control for mutant lines was VC2010. Control for Exon 3 RNAi knockdown was L4440 RNAi
knockdown.

Reagents

Concentration (Volume Used)
cDNA
See dilutions Table 3 (1 uL)
Forward/Reverse Primers (6.25 uM stock)
0.933 uM (2.24 uL)
iTaq Universal SYBR Green Supermix (2X)
1X (7.5 uL)
ddH20
(4.26 uL)
Table 2: Standard qPCR Reaction (15 uL) and reagent components
The qPCR protocol carried out is listed as follows:
10’ 95°C – [1’ 95°C – 1’ 60°C] x40 – 15” 95°C – 1’ 60°C – 15” 95°C.
qPCR Experiments (primers)
Determining cDNA dilution
Measuring exogenous PNPase expression via
FLAG Tag (qPCR PNPT1 FWD FLAGTAG /
qPCR PNPT1 REV FLAGTAG)
Measuring endogenous PNPase expression
(wPNPase ex 9 F / wPNPase ex 10 R)
Measuring actin expression (w act-2 F / w
act-2 R)
Measuring polycistronic transcript
accumulation (ctb-1 F / COIII R)
Measuring total mitochondrial transcripts
(COIII Set 7 F/R)
Table 3: qPCR Experiments and cDNA Dilutions

cDNA Dilutions
1:8 | 1:16 | 1:32 | 1:64
1:16
1:16
1:16
1:4
1:16
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Analysis of C. elegans pnpt-1 Point Mutations
SIFT (Sorting Intolerant from Tolerant) and Polyphen-2 (Polymorphism Phenotyping v2)
were used to determine the predicted deleteriousness or benign-ness of missense mutations
located on pnpt-1. SIFT predicts if amino acid substitutions affect protein function. Both WT
and mutant sequences were inputted into the software to determine the predicted degree of
deleteriousness of the missense mutation. Polyphen-2 determines the possible impact the amino
acid substitution has on protein structure and function. Both WT protein sequence and amino
acid change were inputted into the algorithm.
SIFT: https://sift.bii.a-star.edu.sg/
Polyphen-2: http://genetics.bwh.harvard.edu/pph2/

Determination of Mitochondrial Targeting Peptide (mTP)
Peptide sequence was analyzed using TargetP V1.0 software to determine if worm
PNPase contains an N-terminal mitochondrial targeting sequence or peptide motif. Peptide
sequence was inputted into the software and a predicted score determined if a mitochondrial
targeting sequence was present or not.

TargetP V1.0: http://www.cbs.dtu.dk/services/TargetP-1.0/

Male C. elegans generation
Ten L4 hermaphrodites were transferred on OP50 seeded 60 mm x 15 mm NGM plate.
Worms were heat shocked in 30°C incubator for four hours without parafilm. After heat shock
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treatment, the plates were parafilmed and stored at 20°C. F1 male progeny were isolated after 34 days post heat shock.
To maintain male nematode stocks, males and L4 hermaphrodites were grouped onto a 30
mm x 15 mm plate in a 1:1 ratio and allowed to mate overnight at 20°C. After 24 hours of
mating, hermaphrodites were isolated and singled onto separate OP50 seeded 30 mm x 15 mm
NGM plates. Progeny were allowed to grow and develop for four days. Male progeny were
isolated and used to maintain male stocks or used for backcrossing.

Backcrossing
Mutant hermaphrodites (VC20261, VC40327, VC20284) were backcrossed eight times to
wildtype VC2010 N2 variant strain to produce a predicted 99.61% wildtype background. Each
backcross event was grouped into 2X backcrossing cycles (Figure 8).
Male VC2010 worms and mutant L4 hermaphrodites were transferred onto a 30 mm x 15
mm seeded plate in a 2:1 ratio of males:hermaphrodites for mating. Worms were allowed to
mate overnight at 20°C. Following overnight mating, mated mutant hermaphrodites were singled
onto 30mm x 15mm OP50 seeded plates and allowed to lay progeny for 3 days at 20°C.
Heterozygous male F1 progeny were isolated and mated with VC2010 L4 hermaphrodites in a
2:1 ratio of males:hermaphrodites on a 30mm x 15mm OP50 seeded plate. Worms were allowed
to mate overnight at 20°C. After mating, VC2010 hermaphrodites were singled onto 30mm x 15
mm OP50 seeded plates and allowed to lay progeny for 3 days at 20°C. Adult hermaphrodites of
F1 progeny were singled onto 30 mm x 15 mm OP50 seeded NGM plates and allowed to lay
eggs overnight. Then, the adult hermaphrodites were genotyped using DNA extracted using the
single worm PCR protocol.
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Progeny of heterozygous hermaphrodites were allowed to develop for 3 days to
adulthood. Adult F2 progeny of F1 heterozygous hermaphrodites were singled on 30 mm x 15
mm OP50 seeded NGM plates and allowed to lay eggs overnight. Adult F2 hermaphrodites were
genotyped using the single worm PCR protocol. Extracted DNA was used for genotyping
through PCR and digest protocols to determine the genotype of the adult hermaphrodite.
Progeny of homozygous mutant F2 adult hermaphrodites were maintained, concluding the 2X
Backcross cycle. Four 2X backcross cycles were carried out for each mutant strain to produce
the predicted 99.61% wildtype background. Genotyping consisting of a PCR and Digest
protocol for each mutant strain are listed below in Table 4.
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2X Backcross for Mutant Strains
D1

Mutant Hermaphrodite L4

VC2010 Adult Male

mut / mut

Cross 1

+ / +

D2

Singled mated mutant hermaphrodite adult

D5

F1 Progeny (50% hermaphrodites: 50% males)
mut / +
F1 Male

VC2010 L4 Hermaphrodite

mut / +

+ / +

D6

Singled mated VC2010 hermaphrodite adults

D10

F1 Progeny of Cross II (50% hermaphrodites: 50% males)
mut / +

+ / +

Cross 2

(1:1 Ratio)

Singled F1 Hermaphrodite adults (allowed to self-fertilize and lay embryos O.N.)
D11

Genotyped F1 hermaphrodite adults that were allowed to lay eggs via SWPCR

D15

F2 progeny from heterozygous F1 hermaphrodite adults
+ / +

mut / +

mut / mut

(1:2:1 Ratio)

Singled 5-10 F2 hermaphrodite adults from the heterozygous mutant
hermaphrodite adults from SWPCR of D11 (allowed to self-fertilize and lay
embryos overnight before genotyping)
D16

SWPCR of singled F2 hermaphrodite adults from D15 for genotyping. Singled 8-10
F2 hermaphrodite adults from mutant hermaphrodite adults from SWPCR of D11
(allowed to self-fertilize and lay embryos before genotyping)

D17

SWPCR of singled F2 hermaphrodite adults from d16. Picked worms from
homozygous mutant F2 hermaphrodite adult plates to maintain 2x backcrossed
mutant strain
Tirumala 2012

Figure 8: 2X Backcrossing Mechanism for Mutant Strains
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Sample

Primers

VC40327 (G58E)

PCR Product Size

PNPT1_Genomic_F /
399 bp
PNPT1_Genomic_R
VC20261 (G74R)
VC20286/61_StyI_F
152 bp
/ Reverse 3
VC20284 (G74E)
VC20286/61_StyI_F
152 bp
/ Reverse 3
Table 4: PCR and Digest Protocol for Mutation Genotyping

Digest of Mutation
Allele
218 bp / 181 bp
(BstbI: NEB)
115 bp / 27 bp
(StyI_HF: NEB)
115 bp / 27 bp
(Sty1_HF: NEB)

PCR Purification and Concentration
PCR products were purified and concentrated prior to sequence submissions, TA
Cloning, Gibson Assembly, and Fusion PCR. DNA Clean and Concentrator-5 (D4003), by
Zymo Technologies was used to carry out this protocol. PCR products were mixed with DNA
Binding Buffer in a 1:5 ratio. The mixture was transferred to the Zymo-Spin Column and spun
down for 30 seconds at 13,300 rpm. Flow through was discarded. To the spin column, 200 uL
of DNA Wash Buffer was added and was spun down for 30 seconds at 13,300 rpm. The spin
column was transferred to a 1.7 mL tube and 6-10 uL of DNA Elution Buffer was added to the
column matrix. Column matrix was allowed to incubate at room temperature for one min. The
spin column was then spun down at 13,300 rpm for 30 seconds. DNA sample was stored at 20°C for down stream applications.

Sequencing
DNA samples were Sanger sequenced using Eurofins Genomics sequencing services.
Samples were submitted per company guidelines.
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Gel Electrophoresis
Depending on DNA size or application, gel electrophoresis was carried out on either 1%
Agarose (Seakem LE) in TAE buffer or 6% acrylamide with 0.5X TBE buffer. One percent
agarose gels were used for gel extractions and PCR and digested products greater than 200 bp
used. Genotyping of SW-PCR and allele specific PCR, or PCR and digested products less than
200 bp used 6% acrylamide gels.

Gel Extraction
Desired bands of digest products or PCR products were cut out after performing gel
electrophoresis in agarose gels. Excised sections were placed in Freeze `N Squeeze DNA Gel
Extraction spin columns (Bio-Rad) and placed at -20°C for 5 minutes. DNA was eluted at
13,000 x g for 3 minutes at room temperature. Purified DNA samples were stored at -20°C.

TA Cloning
Sections of the wPNPT1 cDNA were PCR amplified and ligated into pBluescript SK+
that had been prepared by cutting with EcoRV and t-tailed. Prior to ligation, PCR samples were
purified and concentrated. The amount of PCR product used for ligation followed the formula:
X ng PCR product =

(A BC DEF CGHIJKL)(NO /P QRKLHG)
(STUR TV BC HW XRKLHG)

. The ligation reaction used 3x the amount of

PCR product for a 3:1 molar ratio between insert to vector respectively. The reaction consisted
of PCR product, 50 ng of vector DNA, 400 U of T4 DNA Ligase (NEB M0202S), 1x ligation
buffer, and ddH20 to bring the final volume to 10 uL. Ligations were incubated at
14°C overnight.
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Transformations were performed using 1 uL of the ligation mix added to 50 uL of thawed
supercompetent cells (DH5alpha, DH10b, Able C, Able K, or BL21-DE3) and incubated on ice
for 30 minutes. The transformation was heat shocked in a 42°C water bath for 30 seconds
followed with a 2 minute incubation on ice. LB media (950 uL) was added to the mixture and
incubated in a 37°C shaker for 1 hour. Cells were plated onto LB ampicillin plates (0.1 mg/mL
ampicillin) prepped with 20 uL of X-Gal and 0.09 M IPTG. Plates were incubated overnight at
37°C.

Gibson Assembly
Individual cloned fragments of pnpt-1 were assembled using NEBuilder HiFi DNA
Assembly (NEB E2621G). Transformed bacteria containing cloned gene fragments were
miniprepped and digested to isolate pnpt-1 fragments. Digest products were extracted after gel
electrophoresis through Freeze `N Sqeeze DNA Gel Extraction Spin Columns (Bio-Rad).
Protocol for ligating 2-3 fragments in a single reaction (2-3 Fragment assembly) was followed
per manufacturer guidelines.
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PCR Fusion

Figure 9: Outline of PCR Fusion plan to anneal individual segments of pnpt-1, hsp-16.41, and
unc-54 3` UTR. Colored squares represent overlap regions.
Individual segments of pnpt-1, hsp-16.41 promoter, and unc-54 3`-UTR with overlapping
segments were assembled using a series of PCR reactions. The hsp-16.41 promoter, and unc-54
3`-UTR fragments were obtained from PCR reactions using vector pPD48.93 as a template
(Table 5). Fragments were assembled either 2 or 3 at a time using Q5 Hot Start High Fidelity
DNA Polymerase (NEB M0493S). Reaction mix contained equimolar ratio of individual
fragments, Q5 Hot Start High-Fidelity DNA Polymerase, 1X buffer, and ddH20 to volume.
Forward and reverse primers were added unless otherwise stated. Thermocycler protocols are
listed below. Outline of the multistep PCR Fusion Protocol is displayed above in Figure 9.
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Fusion PCR – Step 1: Amplification of the Individual Fragments
The primers, templates, annealing temperatures, fragment sizes to produce the five
fragments for the PCR fusion are described in Table 5. PCR reactions are show in Table 6. PCR
cycles used were 30” 98°C – [10” 98°C – 30” annealing temperature – 40” 72°C] x30 – 2’ 72°C.
Fragment
Produced
hsp-16.41

Primers

Template

PNPT1_Forward_A /
PNPT1_Reverse_B
PNPT1_Forward_C /
PNPT1_Reverse_D

Annealing
Temperature
54.7°C

vector pPD
49.83
wPNPT1
wPNPT1
56.8°C
Fragment 1+2
Fragment 1+2
in vector
pBSSK
wPNPT1
wPNPT1Frag3F /
wPNPT1
58.4°C
Fragment 3 pt 1 wPNPT1_Frag3_pt1_R Fragment 3 part
1 in vector
pBSSK
wPNPT1
wPNPT1_Frag3_pt2_F wPNPT1
58.4°C
Fragment 3 pt 2 / PNPT1_Reverse_H
Fragment 3 part
2 in vector
pBSSK
unc-54 3` UTR PNPT1_Forward_I /
vector pPD
54.7°C
PNPT1_Reverse_J
49.83
Table 5: Primer, Template, Annealing Temperature, and Product Size of Step 1
PCR Protocol
Reagents
Concentration/Amount
(stock concentration)
Used
DNA (2pg/uL stock)
5 uL
5X Q5 Reaction Buffer
5 uL
Q5 HiFi
0.25 uL
dNTPs (2.5 mM stock)
2 uL(0.2 mM)
Primers (6.25 uM stock)
2 uL each (1 uM)
Water (Hyclone)
8.75 uL
Total Volume
25 ul
Table 6: Step 1 PCR Protocol for PCR Fusion

Product
Size
541 bp
1357 bp

558 bp

511 bp

737 bp

Manufacturer
NEB M0495S
NEB M0493S
Bioline
IDT
GE
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Fusion PCR – Step 2A Combining Fragments
To combine the overlapping fragments, the fragments generated above are denatured and
anneal with one another and therefore become both the template and primer for the amplification
reaction. In this step the promoter and pnpt-1 fragment 1 + 2 are combined (fragment 5’) and the
three most 3’ fragments are annealed (fragment 3’) (Table 7). PCR Reaction are shown in Table
8. The cycling parameters used for these reactions were 30” 98°C – [10” 98°C – 30” 58°C – 1’
72°C] x15 – 2’ 72°C.
Fragment
Produced

Templates

Annealing
Temperature

Fragment 5’

Product Size

hsp-16.41 /
1898 bp
58°C
wPNPT1
Fragment 1+2
Fragment 3’
wPNPT1
1809 bp
58°C
Fragment 3 pt1 /
wPNPT1
Fragment 3 pt2 /
unc-54 3` UTR
Table 7: Template, Annealing Temperature, and Product Size of Step 2A

Reagents
Concentration/Amount
(Stock concentration)
Used
DNA
X uL (see table 7)
5X Q5 Reaction Buffer
20 uL
Q5 HiFi
1 uL
dNTPs (2.5 mM stock)
8 uL (0.2 mM)
Water (Hyclone)
X uL to bring to final volume
Total reaction volume
100 ul
Table 8: Step 2A PCR Protocol for PCR Fusion

Equimolar
Concentrations
of Fragments
used
0.22 pmols
0.41 pmols

Manufacturer
NEB M0495S
NEB M0493S
Bioline
GE
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Fusion PCR – Step 2B Generating Additional Copies of Fragments
Step 2B consisted of amplification of fused fragments 5’ and 3’ from Step 2A for use for
the next fusion step (Tables 9 and 10). The fragments were run on a 1% agarose gel and the
fragments were excised and extracted from the gel but not purified cycling parameters were: 30”
98°C – [10” 98°C – 30” annealing temperature – 1’ 72°C] x35 – 2’ 72°C.
Fragment
Produced
Fragment 5’

Primers

Template

PNPT1_Forward_A
/
PNPT1_Reverse_D
wPNPT1Frag3F /
PNPT1_Reverse_J

Annealing
Temperature
59.1 / 60.1°C

PCR fusion
product
Fragment 5’
Fragment 3’
PCR fusion
58 / 59.1°C
product
Fragment 3’
Table 9: Primer, Template, Annealing Temperature, and Product Size of Step 2B
PCR Protocol
Reagents
Concentration/Amount
(Stock concentration)
Used
Gel extracted DNA
2 uL
5X Q5 Reaction Buffer
10 uL
Q5 HiFi
0.5 uL
dNTPs (2.5 mM stock)
4 uL (0.2 mM)
Primers (6.25 uM stock)
4 uL each (1 uM)
Water (Hyclone)
25.5 uL
Total reaction volume
50 ul
Table 10: Step 2B PCR Protocol for PCR Fusion

Product
Size
1898 bp
1809 bp

Manufacturer
NEB M0495S
NEB M0493S
Bioline
IDT
GE
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Fusion PCR – Step 3A Combining of Fragments 5’ and 3’
Step 3A consisted of fusing the two large fragments together at the overlapping region
again with the annealed fragments serving as primer and template. (Tables 11 and 12). This
fragment was called FSN PCR. The PCR cycling parameters were: 30” 98°C – [10” 98°C – 30”
58°C – 2’ 72°C] x15 – 2’ 72°C.
Fragment
Produced

Templates

Annealing
Temperature

Product Size

FSN PCR

Fragment 5’/
3707 bp
58°C
Fragment 3’
Table 11: Template, Annealing Temperature, and Product Size of Step 3A
PCR Protocol
Reagents
Concentration/Amount
(Stock concentration)
Used
DNA
X uL (see table 11)
5X Q5 Reaction Buffer
20 uL
Q5 HiFi
1 uL
dNTPs (2.5 mM stock)
8 uL (0.2 mM)
Water (Hyclone)
X uL to bring to final volume
Totalreaction volume
100 ul
Table 12: Step 3A PCR Protocol for PCR Fusion

Equimolar
Concentrations
of Fragments
used
0.23 pmols

Manufacturer
NEB M0495S
NEB M0493S
Bioline
GE

Fusion PCR – Step 3B Generating Additional Copies of the Fused FSN PCR Product
Step 3B consisted of amplification of the FSN PCR product created from Step 3A with
nested primers to generate material for worm injections (Tables 13 and 14). PCR protocol ran as
follows: 30” 98°C – [10” 98°C – 30” 58°C – 2’ 72°C] x35 – 2’ 72°C.
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Fragment
Produced
FSN PCR

Primers

Template

Annealing
Temperature
58°C

PNPT1_Nested_Forward FSN PCR
/ PNPT1_Reverse_J
Table 13: Primer, Template, Annealing Temperature, and Product Size of Step 3B
PCR Protocol
Reagents
Concentration/Amount
(Stock concentration)
Used
Gel Extracted DNA
3 uL
5X Q5 Reaction Buffer
10 uL
Q5 HiFi
0.5 uL
dNTPs (2.5 mM stock)
4 uL(0.2 mM)
Primers (6.25 uM stock)
4 uL each (1 uM)
Water (Hyclone)
24.5 uL
Total Reaction Volume
50 ul
Table 14: Step 3B PCR Protocol for PCR Fusion

Product
Size
3707 bp

Manufacturer
NEB M0495S
NEB M0493S
Bioline
IDT
GE

pnpt-1 Overexpression Transgenic Line Generation
Microinjections were carried out in young adult hermaphroditic worms into VC2010 or
CF3152 strains by Dr. Laura Mathies. Equal amounts (100 ng) of pPD49.83 heat shock vector
or FSN PCR (PCR Fusion construct) with pTG96 suf-5::GFP reporter vector were added in a 40
uL reaction mix. Reaction mixes were injected into the gonad arm of young adult
hermaphrodites. suf-5::GFP is expressed in the nucleus of somatic cells (Gonzalez-Serricchio et.
al., 2006) and serves as a co-injection marker.

Transgenic Line Stabilization
Stable transgenic pnpt-1 overexpression VC2010 and CF3152 lines were selected over
three generations. For each generation, five to ten GFP expressing hermaphrodites were singled,
allowed to mature, and produce eggs and the progeny screened for GFP-expression. Regular
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nematode maintenance followed after stabilization of the line and propagated with GFPexpressing animals.

Overexpression of pnpt-1
Method 1
Ten adult transgenic hermaphrodites expressing GFP were transferred onto medium
OP50 seeded plates. Plates were parafilmed and placed in 20°C for 4 days until F1 progeny
developed into adults. GFP-expressing nematodes were heat shocked for 2 intervals of 2 hours
at 30°C without parafilm with a 30 min break at 20°C between the two heat shock incubations.

Method 2 (Cancer Models)
Five adult transgenic hermaphrodites expressing GFP were transferred onto medium gld1 RNAi seeded plates. Plates were parafilmed and placed in 20°C for 3 days until F1 progeny
developed into L4’s. Plates were heat shocked at 30°C for 2 hours at L4 stage (day 3) and adult
stage (day 4) without parafilm. Worm plates were parafilmed and stored at 20°C in between
when worms were heat shocked.

Western Protocol
Protein Extractions
Ten L4 hermaphrodites were transferred to newly seeded NGM plates. Each strain was
staged on 5 plates. Progeny were allowed to develop for 4 days at 20°C prior to sample
preparation for protein extraction. Plates of nematodes were washed with 1mL of M9 2X and
collected in a 15 mL tube. Worms were pelleted at 1,000 rpm for 5 minutes, and the supernatant
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was discarded . They were then washed with 5 mLs of fresh M9 buffer 3X. Protease inhibitor
cocktail (Sigma 8340) was added in a 1:100 dilution to the 300 uL worm pellet in M9 prior to
storage in -80°C. When ready to use worm pellets were thawed and transferred to a 1.7 mL tube
and 200 uL of 1X RIPA Buffer (Cell Signaling Technologies #9806) was added to the pellet.
Samples were homogenized with a pellet pestle for 2 minutes. They were then placed on ice and
gently rocked on a platform shaker for 20 minutes at 4°C. Samples were spun down at 13,300
rpm for 1 minute at 4°C. Supernatant consisting of protein lysates was transferred to a new 1.7
mL tube and kept on ice to measure the concentration using the Lowry Assay.

Lowry Protein Assay
The DC Protein Assay (Bio-Rad) was used to measure concentrations of protein lysates.
A standard curve was generated using 25 uL BSA standards (0.125 mg/mL, 0.25 mg/mL, 0.5
mg/mL, 1 mg/mL, and 1.4 mg/mL). Protein lysates were diluted with ddH20 to a 1:5 ratio
respectively. Final version of Reagent A was prepared by mixing a ratio of 20 uL of Reagent S
and 1 mL of Reagent A. Then, final version of reagent A (125 uL) mix and Reagent B (1mL)
were added to 25 uL BSA standards and protein samples and samples were inverted 5 times to
mix the reagents. Samples were allowed to incubate at room temperature for 15 minutes. BSA
standards were read at 750 nm with Beckman Coulter DU 530 DNA/Protein Analyzer
Spectrophotometer to produce the standard curve. Protein lysates were read and plotted against
the standard curve to determine concentration. Protein lysate samples were aliquoted into 50 ug
aliquots and stored at -80°C.
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Western Analysis
4X Laemmli Sample Buffer (BioRad – 161-0747) was added to the 50 ug aliquots of
protein lysates to bring the final concentration of Sample Buffer to 1X. Samples were boiled at
100°C for 10 minutes followed bypelleting in a 4°C centrifuge at 13,300 rpm for 30 seconds.
Supernatents were loaded onto a 7.5% acrylamide resolving gel and a 3.9% acrylamide stacking
gel with 10 uL protein standard (Bio-Rad 161-0374). Gel electrophoresis of the protein lysates
was carried out at 100 volts for ~2 hours in 1X Tris glycine running buffer. After gel
electrophoresis, the stacking gel was discarded and the resolving gel was prepped for transfer.
The gel was soaked in 1X transfer buffer for >15 minutes and the protein lysates were transferred
onto an Immun-Blot PVDF Membrane for Protein Blotting (Bio-Rad 162-0177). The membrane
was prepped prior to the transfer step by soaking in cold methanol for 15 seconds, ddH20 for 2
minutes, then 1X transfer buffer for > 5 minutes.
The transfer step was carried out in 1X transfer buffer with methanol for ~2 hours at 100
volts with an ice block in the gel box. During the 2 hour transfer, the ice block was replaced
with a new ice block every 30-40 minutes to keep the gel box cold. After the transfer step, the
membrane was removed from the cassette and rinsed in TBS for 10 minutes on a platform shaker
at room temperature.

Block / Primary Ab / Secondary Ab
After blocking for 4 hours at room temperature, membranes were rinsed in TBST prior to
incubation in primary Ab overnight at 4°C. After primary Ab incubation, membranes were
washed in TBST for 3 x 10 minutes on platform shaker prior to secondary Ab application. After
secondary Ab incubation, membrane was rinsed 2 x 10 minutes in 5% milk/TBST, rinsed in
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TBST, and then washed in TBST for 10 minutes on platform shaker. Parameters for protein
detection of specific antibodies are found in Table 15.
Antibody (Experiment)
Block
FLAG Tag
5% milk/TBST
(Determining exogenous
PNPase protein
synthesis)

Primary Ab
Monoclonal Anti-FLAG
M2 Produced in Mouse
(Sigma F1804)
1:1000 dilution in 3%
milk/TBS
Incubate covered at 4°C
overnight

alpha-Tubulin (loading
control)

5% milk/TBST

Anti-alpha-Tubulin
(Mouse Monoclonal)
(Sigma T6199)
1:5000 dilution in 5%
milk/TBST
Incubate covered at 4°C
overnight

Secondary Ab
ECL Anti Mouse IgG
Horseradish Peroxidaselinked Whole Antibody
from Sheep (GE
Healthcare NA931V)
1:10,000 dilution in 5%
milk/TBST
Incubate covered for
~45 min at room
temperature on platform
shaker
ECL Anti Mouse IgG
Horseradish Peroxidaselinked Whole Antibody
from Sheep (GE
Healthcare NA931V)
1:10,000 dilution in 5%
milk/TBST
Incubate covered for
~45 min at room
temperature on platform
shaker

Table 15: Parameters and Conditions for Antibodies
Detection
Antibodies were detected through chemiluminescence using Super Signal West Femto
Maximum Sensitivity Substrate Kit (ThermoFisher 34096). Stable Peroxide Solution and
Luminol/Enhancer Solution were mixed in a 1:1 ratio. Membranes were placed in the detection
solution protein-side down and incubated at room temperature for 5 minutes and wrapped in
plastic wrap. Membraned were exposed to X-ray film in a dark room for 5-10 seconds and then
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15-30 seconds. Film was developed in a Kodak film developer. Membrane was stored in TBS at
4°C.

Stripping
BlotFresh Western Blot Stripping Reagent Ver II (SignaGen Laboratories SL100324)
reagent was used to strip membranes prior to reapplication of antibodies. Membranes were
placed in 30 mLs of stripping reagent on a platform shaker for 10 minutes at room temperature.
Membraned were then washed in TBST for 2X 10 minutes on a platform shaker.
Immunofluorescence
Poly-L-Lysine Slide Preparation
ColorFrost Plus Slides (Fisher Scientific) were coated with poly-L-Lysine solution
(Sigma Aldrich P8920). Poly-L-Lysine solution was diluted 1:1 with ddH20. Slides were
briefly heated at “setting 4” on a hot plate. Ten microliters of solution was added to one heated
slide and sandwiched to another heated slide to spread solution. Slides were separated and
residual Poly-L-Lysine solution were left to dry at room temperature.

Edgar Buffer Dissecting Media
Worms were dissected in 20 uL of Edgar’s Buffer. Buffer consisted of 60 mM NaCl, 32
mM KCl, 3 mM Na2HPO4, 2 mM MgCl2, 2 mM CaCl2, 5 mM HEPEs, 0.2% glucose pH 7.2.
The buffer was filter sterilized and stored in 4°C. Levamisole hydrochloride (Sigma L-9756) at
25 mM concentration was added to Edgars Buffer in a 1:100 ratio prior to dissection.
Levamisole served as a paralytic aide for gonad isolation and dissection.
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Gonad Isolation
Worms were placed in 20 uL of Edgar’s Buffer with 0.25 mM levamisole on a poly-LLysine coated charged slide. A 30 gauge needle was used to open the nematode at the pharynx.
Gonad arms and the other internal organs were separated using an eyebrow hair attached to a
tooth pick. Four dots of vacuum jelly were placed around the dissection media and a 22 mm x
50 mm coverslip (Fisherbrand 12-543-C) was placed on top and slightly depressed until touching
the gonad arms and dissected worms. Slide was then placed in liquid nitrogen until all
dissections were completed. Upon completion, slides were taken out of liquid nitrogen and
freeze-cracked by flicking off the coverslip. Slides were immediately placed in fixation media.

Fixation
Samples were fixed in cold 100% methanol for 4 minutes followed by 4 minutes in cold
acetone. Coplin jars contained Type 3A molecular sieves at the bottom of the jar for static
dehydration in the fixation media. Fixation media was chilled in wet ice for >15 minutes prior to
fixation of dissected samples after freeze cracking.
Following fixation, slides were washed in 1X PBS for 3X for 5 minutes on a platform
shaker. Slides were soaked in 50 mL blocking solution in a coplin jar and incubated for ~20
minutes on platform shaker at room temperature. Blocking media consisted of 0.5% BSA,
0.04% azide, and 0.01% Tween-20 in 1X PBS. Reagent was filter sterilized with Steriflip
Vacuum-driven Filtration System with 0.22 um membrane (Millipore Sigma – SE1M179M6)
and stored at 4°C.
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A hydrophobic ring was placed around the sample on the slide with vacuum grease (Dow
Corning High Vacuum Grease) and 30 uL primary antibody solution was pipetted on top of the
samples.
Samples were incubated with primary antibody for 2 hours in a humid chamber. Humid
chamber consisted of a Tupperware container with soaked paper towels lining the bottom and
pipette tip wafers serving as an elevated platform for the slides. Antibody buffer solution
consisted of 3% BSA, and 1% azide in sterile ddH20. The reagent was filter sterilized with
Steriflip Vacuum-driven Filtration System with 0.22 um membrane (Millipore Sigma –
SE1M179M6) and stored at 4°C. Following primary antibody incubation, slides were washed in
1X PBS 3X for 10 min on a platform shaker. Excess 1X PBS was wiped off and 30 uL of
secondary antibody solution was pipetted on top of the sample. Samples were incubated in the
dark for 2 hours in a humid chamber. Slides were then washed in 1X PBS for 3 X five minutes
on a platform shaker and dip washed in ddH20. Excess solution and hydrophobic grease ring
was wiped off using a kimwipe. Five to ten microliters of Fluoro-Gel II Mounting Medium
(Electron Microscopy Sciences 17985-50) solution was added to an 18 mm x 18 mm coverslip
and coverslip was placed on top of the slide covering the sample. Samples were incubated
overnight at 4°C in a slide folder. Antibody information for primary and secondary antibodies
and the double staining protocol for FLAG-Tag and K76 are listed in the tables below (Table 16
and 17).
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Antibody
K76 (Developmental Studies Hybridoma
Bank)
Rabbit ANTI-FLAG antibody (Sigma F7425)

Description
Anti-PGL-1 for p granules detection

Polyclonal Flag tag antibody produced in
rabbit
Donkey anti-Mouse IgG (H+L) Highly Cross- Alexa Fluor 488 Donkey anti Mouse
Adsorbed Secondary Antibody, Alexa Fluor
488 (Thermo Fisher A21202)
Donkey anti-Rabbit IgG (H+L) Highly Cross- Alexa Fluor 568 Donkey anti Rabbit
adsorbed Secondary Antibody, Alexa Fluor
568 (Thermo Fisher A10042)
Table 16: Primary and Secondary antibody list and associated description
Protocol

Primary Ab

Secondary Ab

FLAG-Tag and K76

Anti-Flag (Rabbit): 1:3000
dilution

Alexa Fluor 488 Donkey anti
Mouse: 1:4000

K76: Final concentration of 5
ug/mL
Table 17: Double Staining Protocol for FLAG-Tag and K76

Alexa Fluor 568 Donkey anti
Rabbit: 1:4000

ROS Assay
Seven L4 hermaphroditic worms were picked onto RNAi or NGM plates and allowed to
mature and lay eggs overnight (up to 24 hours). Adults were removed from the plates the next
day and eggs were allowed to mature into adults over the next three days. At least 150 adult
hermaphrodites were picked and transferred to a new seeded RNAi or NGM plate. For
transgenic lines, adult GFP-expressing hermaphrodites were picked and transferred to a seeded
NGM plate. Fifty worms were individually picked and dropped into 0.65 mL tubes containing
250 uL of 1X Sample Buffer from AmplexRed (Life Technologies) kit in triplicate. Worms
were spun down at 15,000 rpm for 2 min and 150 uL of supernatant was removed. Worms were
washed for a total of 4X. One hundred microliters of 1X Sample Buffer was added to the tube
and samples were pulsed on a vortex at maximum speed. Tubes were spun down at 1,000 rpm
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for 2 mins and 100 uL of supernatant was removed. Fifty uL of worms/1X Sample Buffer
mixture were aliquoted into a 96 well plate.
DMSO and 1 vial of Amplex Red Reagent were allowed to thaw to room temperature
while covered from light. Sixty uL of thawed DMSO was added to the Amplex Red Reagent
vial to dissolve the contents. This step was done right before preparing the working solution.
1X Sample Buffer was prepared by diluting 4 mL of 5X Sample Buffer with 16 mLs of sterile
deionized water. Next, 22.7 uL of 3% HZ OZ was mixed with 977 uL of 1X Sample Buffer to
produce 20 mM HZ OZ . The 20 mM HZ OZ diluted stock was further diluted to 0.01 mM in 1X
Sample Buffer to produce the positive control. 1X Sample Buffer served as the negative control.
A vial of Horseradish Peroxidase (HRP) was mixed with 1 mL of 1X Sample Buffer. The
solution was divided into single use 100 uL aliquots and stored at -20C.
After transferring worm samples and the positive and negative controls to the 96 well
plate, a working solution were prepared with 100 uM Amplex Red Reagent and 0.2 U/mL HRP.
Fifty microliters of working solution was added to each sample well. The 96 well plate was
loosely covered with parafilm and incubated at room temperature and covered from light.
Absorbance readings were taken with a BioTek SYNERGY|HTX multimode reader at 540 nm
and 620 nm after 30 minute incubation and 2.5 hour incubation. Measured values were analyzed
with Gen5 2.06 software.
Final amounts of HZ OZ was determined by subtracting the 540 nm absorbance values
from the 620 nm absorbance values. Triplicates were averaged and significance of differences
were determined with a t-test.
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Table 18 – Primer List
Primer Name
wPNPT1_Genomic_F
wPNPT1_Genomic _R

Sequence
AGT GGA ATC GAG CTG
AAA GC
TTG CTG ACG CTG ACG
GTC T

VC40327_G_F

GTA AGA CCG TAG TTG
CTT CAT TCC G

VC40327_A_F

ACT CTA GTA GAC ATA
ACC GTA GTT GCT TCA
TCC GA
CCG ATA TTC AAC TTG
TAG CGG

Reverse 2
VC20284_G_F

GTA AGC AAC GGA AAT
CCA AGC AAC G

VC20284_A_F

AAG CAT CTC AAG CAT
CAA CGG AAA TCC AAG
CAG GA
GCT GAC GGT CTG GAA
TTT TCA G

Reverse 3
VC20261_G_F

CAG AGC AAC GGA AAT
CCA AGC ATG

VC20261_A_F

GAA GCA TCT CAA GCA
CAA CGG AAA TCC AAG
CGA A
CCG CAG GTA GTA CAA
CGG AAA TCC AAC CAA

VC20284/61_StyI_F
PNPT1_Nested_Forward

GCA GGT CGA CTC TAG
AGG ATC AC

PNPT1_Forward_A

ATG ACC ATG ATT ACG
CCA AGC
GGC AAC CGG GAA AGT
TTC ATA GAT ATC AAT
ACC ATG GTA CCG TCG

PNPT1_Reverse_B

Notes/Desc
For sequencing mutant strains
For sequencing mutant strains
and reverse primer for allele
specific PCR for VC20284
and VC20261
Allele specific PCR for
genotyping for VC40327
(Mutant allele)
Allele specific PCR for
genotyping for VC40327
(wildtype allele)
Allele specific PCR for
genotyping for mutant line
VC40327
Allele specific PCR for
genotyping for VC20284
(mutant allele)
Allele specific PCR for
genotyping for VC20284
(wildtype allele)
Allele specific PCR for
genotyping for mutant lines
VC20284 and VC20261
Allele specific PCR for
genotyping for VC20261
(mutant allele)
Allele specific PCR for
genotyping for VC20261
(wildtype allele)
Allele specific PCR for
genotyping for VC20261 and
VC20284
Primer for amplifying final
Fusion PCR construct and
sequencing Fusion PCR
construct
Fusion PCR: Forward primer
for hsp-16.41 promoter
Fusion PCR: Reverse primer
for hsp-16.41 promoter
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PNPT1_Forward_C
PNPT1_Reverse_D
wPNPT1Frag3F

ATG AAA CTT TCC CGG
TTG CC
AAA CCT GGC ATG CGA
GCC GT
GCC GAT TTC CCA TAC
GCC AC

wPNPT1_Frag3_pt1_R

CTG AGC CAA CAG TGA
GAT GTG AGC

wPNPT1_Frag3_pt2_F

GCA AGT TGA TCG AGG
CGG AG

PNPT1_Reverse_H

GGA CTT AGA CAG AGG
CAC GGT CAC TTG TCG
TCA TCG TCT TTG TAG
TCC
CCG TGC CTC TGA CTT
CTA AGT CC
CGT ACG GCC GAC TAG
TAG GAA
TCA GGA GGA CCC TTG
GCT AGC GTC
GAG CAT GTA GGG ATG
TTG AAG AGT AAT TGG
CGG TAC CAT GGT ATT
GAT ATC TAT GAA AC
CAG AGG CAC GGT CAC
TTG TCG
AGT GCT CCG CGA CAC
CAC
GAC TGA AGC CAT TGA
TGA TGA GCC
GCG ATG AGC ACA CTG
GAA ATA
CGT CAT CGT CTT TGT
AGT CCT TT
TCA CTT GTC GTC ATC
GTC TTT GTA GTC CTT

PNPT1_Forward_I
PNPT1_Reverse_J
FSNPCR_Seq_Check_F
FSNPCR_Seq_Check_R
FSN_Seq_CheckV2_F
FSN_Seq_CheckV2_R
PNPT1_Missing_F
PNPT1_Missing_R
qPCR PNPT1 FWD
FLAGTAG
qPCR PNPT1 REV
FLAGTAG
wPNPT1 Frag3 FLAG_R

Fusion PCR: Forward primer
for wPNPT1 Fragment 1+2
Fusion PCR: Reverse primer
for wPNPT1 Fragment 1+2
Fusion PCR: Forward primer
for wPNPT1 Fragment 3 part
1 | Forward primer for
wPNPt1 Fragment 3 pt1 for
cloning
Fusion PCR: Reverse primer
for wPNPT1 Fragment 3 part
1 | Reverse primer for
wPNPT1 Fragment 3 pt1 for
cloning
Fusion PCR: Forward primer
for wPNPT1 Fragment 3 part
2 | Forward primer for
wPNPt1 Fragment 3 pt32for
cloning
Fusion PCR: Reverse primer
for wPNPT1 Fragment 3 part
2
Fusion PCR: Forward primer
for unc-54 3` UTR
Fusion PCR: Reverse primer
for unc-54 3` UTR
Sequencing Fusion PCR
construct in transgenic strains
Sequencing Fusion PCR
construct in transgenic strains
Did not use
Did not use
Sequencing section of FSN
PCR construct of wPNPT1
Sequencing section of FSN
PCR construct of wPNPT1
qPCR for exogenous
wPNPT1 expression
qPCR for exogenous
wPNPT1 expression
Amplification of Fragment 3
of wPNPT1 for cloning
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COIII FWD Set 7

TTT TTT CTG TGA CGT
GGC AGG TG
ACA GTA ACT TGA GCA
CAT CAC A

COIII REV Set 7

AAA TGC TAA GAA CAA
ACC ACC AC

COIII FWD Set 3

GCC TCA GC GGA ATG
TTA

COIII REV Set 3

GTG ATC AAG TCT CTC
CCA ACT C

ctb-1 F

AAG ATG ACT AGG TCA
ATG CA
TAT GCA TAC CTT GAA
AGT CT
ATC GTC CTC GAC TCT
GGA GAT G
TCA CGT CCA GCC AAG
TCA AG
ATG ATG AAT GAT GTG
CTC GA
GGA TTC AGG CTT AGG
TGG TT

COIII R
w act-2 F
w act-2 R
wPNPase ex 9 F
wPNPase ex 10 R

Measuring total
mitochondrial transcripts with
qPCR
Measuring total
mitochondrial transcripts with
qPCR
Measuring total
mitochondrial transcripts with
qPCR
Measuring total
mitochondrial transcripts with
qPCR
qPCR testing for
polycistronic transcripts
qPCR testing for
polycistronic transcripts
Worm actin | loading control
for qPCR
Worm actin | loading control
for qPCR
qPCR for total PNPase
expression
qPCR for total PNPase
expression
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Table 19 – Primer Annealing Temperature
Primer Pairs
Annealing Temperature
wPNPT1 Frag 3F / wPNPT1 Frag 3
60°\
FLAGR
wPNPT1 Frag 3F / wPNPT1 Frag 3
60°\
pt1 R
wPNPT1 Frag 3 pt2 F / wPNPT1
60°\
Frag 3 FLAG R
wPNPT1_Genomic_F /
58°\
wPNPT1_Genomic_R
VC40327_G_F / Reverse 2
55 / 60 / 63 / 65.1 / 66.6°C
VC40327_A_F / Reverse 2
60 / 65.1 / 66.6°C
VC20284_G_F / PNPT1 Genomic R
58 / 60°C
VC20284_G_F / Reverse 3
58 / 60 / 63 / 66.6 / 68.7°C
VC20284_A_F / PNPT1 Genomic R
58 / 60°C
VC20284_A_F / Reverse 3
58 / 60 / 63 / 65.1 / 66.6 /
68.7 / 70.3°C
VC20261_G_F / Reverse 3
55 / 63 / 65.1 / 66.6 / 68.7 /
70.3°C
VC20261_A_F / Reverse 3
55 / 58 / 60 / 63 / 65.1 / 66.6
/ 68.7 / 70.3°C
VC20284/61_StyI_F / Reverse 3
63°C
PNPT1_Forward_A /
54.7°C
PNPT1_Reverse_B
PNPT1_Forward_C /
56.8°C
PNPT1_Reverse_D
wPNPT1Frag3F /
58.4°C
wPNPT1_Frag3_pt1_R
wPNPT1_Frag3_pt2_F /
58.4 / 59 / 59.7 / 60 / 60.5 /
PNPT1_Reverse_H
61°C (3 temperatures used)
PNPT1_Forward_I /
54.7°C
PNPT1_Reverse_J
PNPT1_Forward_A /
59.1 / 60.1°C
PNPT1_Reverse_D
Forward E / PNPT1_Reverse_J
58 / 59.1°C
PNPT1_Nested_Forward /
58°C
PNPT1_Reverse_J
FSNPCR_Seq_Check_F /
60°C
FSNPCR_Seq_Check_R
PNPT1_Missing_F /
58.2 / 59 / 60.1 / 61.1 /
PNPT1_Missing_R
61.7°C
qPCR_PNPT1_FWD_FLAGTAG /
60°C
qPCR_PNPT1_REV_FLAGTAG
wPNPase ex9 F / wPNPase ex10 R
]^°C
COIII Set 3 FWD / COIII Set 3 REV
60°C

Product Size
919 bp
554 bp
443 bP
399 bp
110 bp
120 bp
154 bp
146 bp
164 bp
156 bp
147 bp
157 bp
152 bp
541 bp
1357 bp
558 bp
511 bp
737 bp
1898 bp
1898 bp
3707 bp
3074 bp
427 bp
102 bp
161 bp
283 bp
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COIII set 7 FWD / COIII Set 7 REV
60°C
w act-2 F / w act-2 R
60°C
ctb-1 F/COIII R
60°C
** Bold temperatures used and finalized after optimizing conditions

219 bp
101 bp
231 bp
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Chapter 3: Results
Mutant Studies of PNPase in C. elegans
The goal of the mutant studies was to identify strains that contained mutations located in
pnpt-1 and to determine how their phenotypes compared to the knockdown and overexpression
studies.

Missense Mutation Analysis
Mutant strains with homozygous mutations within pnpt-1 were identified and selected
from the Caenorhabditis Genetics Center. Mutations were induced through EMS and ENU
mutagens on VC2010 (N2 wildtype derivative). Independent clonal lines were allowed to self
proliferate, driving individual mutations to homozygosity (Thompson et. al., 2013). Of the 24
strains available, none of them presented nonsense mutations while all of them presented
homozygous missense mutations in exons of the gene. All missense mutations were analyzed
through SIFT and Polyphen-2 software to determine the predicted effect of the mutation on gene
function. A score of 1 or close to 1 in Polyphen-2 predicted the mutation to be deleterious while
a score of <0.05 in SIFT predicted the mutations to be deleterious. Among the 24, G58E
(VC40327), G74R (VC20261), and G74E (VC20284) were selected (Table 20). G58E and
G74R mutations were predicted to be deleterious or damaging while G74E was predicted to be
benign. G74E and G74R were selected due to differences in their predicted
deleteriousness/benigness while having a missense mutation affecting the same amino acid.
G58E was selected as another predicted deleterious mutant strain to serve as a comparison with
G74R, also a predicted deleterious mutant strain. All three mutations were found to be located in
the first catalytic domain of pnpt-1. These specific strains were selected to determine if
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predicted disruption of the protein within the first catalytic RNase PH domain would affect
normal protein function. One study identified compound heterozygous missense mutations, one
in the first RNase PH domain and one in the second RNase PH domain, in the PNPT1 gene that
produced a disease phenotype (Alodaib et. al., 2016). The RNase PH domains provide the
exoribonuclease function of PNPase. Although there are two RNase PH domains, selecting
strains with mutations in the first catalytic domain would determine if the mutation affects total
protein function, if the mutation results in reduced PNPase function as a result of disrupting the
first RNase PH domain and not the second, and if both RNase PH domains are required for
normal protein function.
Since mutant lines were generated through random mutagenesis with EMS and ENU at
the Caenorhabditis Genetics Center, each line was backcrossed with VC2010, N2 wildtype
derivative, for a total of eight times to generate a predicted 99.61% wildtype background to
remove unlinked mutations located outside of pnpt-1.
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Table 20: Mutant strains available for pnpt-1. SIFT predicted the effects of amino acid substitution on protein function. Polyphen2 determined the impact amino acid substitution has on protein function and structure. The mutants highlighted in green were used for
this study. A score of 1 from Polyphen-2 and a score of 0 or close to 0 identified the missense mutation as predicted to be deleterious.
Strains with mutations located in the first catalytic RNase PH domain include gk747448, gk576099, gk327843, gk165911, gk165912,
gk165915, and gk388087. Strains with mutations located in the second catalytic RNase PH domain include gk165917, gk347759,
gk360199, gk364277, gk379909, gk715189, gk779183, and gk803047. Strains with mutations located in the S1 domain include
otn17845, and otn7416
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Endogenous PNPase Expression of Mutants
In both laboratory models and human studies, mutations located in the gene coding
(exon) regions of pnpt-1 could reduce normal protein function and or prevent trimeric formation
of the protein (Vedrenne et. al., 2012; Golzarroshan et. al., 2018). Specifically, mutations in the
second catalytic RNase PH domain resulted in lower RNA binding and degradation activities
(Golzarroshan et. al., 2018). Depending on the severity of the mutation, missense mutations in
pnpt-1 have been shown to contribute to a disease phenotype in a human study setting. Although
the mutations were not located in the regulatory regions of the gene, PNPase expression was still
quantified using qRT-PCR with primers that spanned the exon 9 and exon 10 junction to
determine if PNPase expression was altered with the selected mutations. In a comparison to
VC2010, the N2 wildtype derivative, strains G74R, G58E, and G74E showed no significant
difference in PNPase expression (p=0.07) (Figure 10).

Figure 10: PNPase Expression in Mutant Strains. PNPase expression in mutant lines were
not significantly different than wildtype (p=0.07) (n=3)
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Polycistronic Transcript Accumulation
The genome of the mitochondria is a circular piece of DNA that is transcribed as a single
polycistronic transcript where a single mRNA can code for several proteins upon RNA
processing into individual RNA molecules (Figure 11). One of the enzymes responsible for
processing polycistronic transcripts in the mitochondrion and excising intervening tRNAs is
RNase P. Since RNase P is one of the RNA molecules transported by PNPase, the goal of this
experiment was to determine if mutations in PNPase affected accumulation and processing of
polycistronic transcripts as a result of disrupted transport of RNase P RNA into the
mitochondria. Previous knockdown studies determined that a decrease in PNPase expression
resulted in an increase in polycistronic transcript accumulation (Laura 2015). To determine the
degree of polycistronic transcripts accumulation, total mitochondrial and polycistronic transcripts
were quantified. This data would allow determination of percentage of polycistronic transcripts
among total mitochondrial transcripts produced. The amount of polycistronic transcripts were
quantified using qRT-PCR with primers at the region between ctb-1 and COIII. When compared
to VC2010 wildtype worms, polycistronic transcript accumulation was not significantly different
in the mutants (p=0.31). Samples G58E and G74E each produced one outlier among the three
trials that contributed to the high error bars and high variance. G74R presented a 0.59x fold
change, G58E presented an 8.72x fold change, and G74E presented a 10.21x fold change (Figure
12).
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Figure 11: Mitochondrial DNA Gene Map of C. Elegans. Locations of the protein coding
genes (gray arrows), tRNAs (circles), and rRNAs (black arrows) coded by the mitochondrial
genome. Genes are transcribed as a polycistronic transcript and later processed to single RNA
species. (From wormbook.com)

Figure 12: Polycistronic Transcript Accumulation. Polycistronic transcript accumulation
were not significantly different in the mutants when compared to VC2010 wildtype(p =
0.31)(n=3)
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Total mitochondrial transcripts, both processed and polycistronic, were quantified using
qRT-PCR by measuring the expression of COIII. When comparing to VC2010 wildytpe, G58E
show a trend of a large increase while G74E presented a trend of a modest increase for total
mitochondrial transcripts (Figure 13). Due to technical errors with the qRT-PCR protocol, the
experiment was only attempted once and no statistical analysis was carried out.

Figure 13: Total Mitochondrial Transcripts measured by qRT-PCR. Mutant strains
presented variations in amount of total mitochondrial transcripts compared to VC2010. No
statistical analysis could be carried since this was a single run (n=1) and all results are presented
as trends.
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ROS Assay
ROS are produced as a by-product of cellular respiration from the respiratory chain
complex, specifically at Complex I and III. Large accumulation of ROS can damage proteins,
lipids, and DNA while low accumulation of ROS can serve as activators for signaling pathways.
Previous work on knockdown of PNPase expression through RNAi concluded that decreased
PNPase expression correlated with an increase in ROS production (Lambert 2015). The purpose
of this experiment was to determine if mutations in PNPase altered ROS production and when
compared to the VC2010 wildtype.
ROS production was quantified using the Amplex Red kit that served as an assay for
quantifying peroxidase activity when !" #" , a reactive oxygen species, was present. Specifically,
in the presence of a peroxidase, the Amplex Red Reagent reacts with !" #" in a 1:1 ratio to
produce resorufin, a red fluorescent oxidation product. Resorufin production could be quantified
by absorbance since the product had an excitation and emission spectrum of 571 nm to 585 nm.
As result, the absorbance values produced are listed as followed: 0.018 for VC2010, 0.021 for
G74R, 0.022 for G58E, and 0.025 for G74E. ROS production in the 3 mutants was not
significantly different than wildtype (p=0.61) (Figure 14).
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Figure 14: ROS production in Mutant Strains. ROS production analysis in mutant strains
showed no difference when compared to the VC2010 wildtype (p = 0.61)(n=3).
Overexpression Studies
The goals of the overexpression studies were to generate an overexpression animal model
in C. elegans, observe the phenotypic effects PNPase overexpression, and compare it to the
results from the knockdown and mutant studies. Initial attempts to clone the pnpt-1 gene into the
pPD49.83 vector failed. Multiple variations and protocol optimizations to clone pnpt-1 included
using different competent cells and adjusting transformed bacteria growth conditions, but none
worked. It was concluded that a 3` fragment of pnpt-1 was toxic to the bacterial competent cells.
As a result, Fusion PCR allowed for ligation of the individual fragments of pnpt-1, and the hsp16.41 promoter and unc-54 3` UTR from the pPD49.83 vector without propagation in E. coli.
Ligation of the individual components occurred at overlapping regions of each fragment to
produce a linear construct for heat shocked induced expression of exogenous PNPase.
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Generation of Transgenic Lines
Transgenic strains of C. elegans were generated to create an overexpression model of
PNPase. Upon completion of the PCR Fusion construct of pnpt-1, equimolar amounts of
construct and pTG96 plasmid or empty vector control pPD49.83 and pTG96 plasmid were
microinjected in the gonad arms of VC2010 and CF3152 strains. Transgenic VC2010 lines
would serve as a comparison to both wildtype and mutants lines. CF3152 strains were
microinjected to be later used for the cancer model studies through knockdown of gld-1with
RNAi. pTG96 is a sur-5::GFP injection marker that allows GFP expression in somatic cells,
serving as a tool to determine the success of transgenic strain synthesis. Microinjected worms
were first selected for GFP expression and singled to generate individual lines. Individualized
lines were allowed to propagate for at least three generations to obtain stable lines. Lines that
maintained GFP expression were selected for maintenance of transgenic lines and for subsequent
experiments (Figure 15, Table 21). As a result, progeny of the microinjected worms were
successfully transgenic and stable with consistent expression of GFP.
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Figure 15: Adult and young adult transgenic C. elegans. GFP expression is visible
throughout the body length of the nematode due to the sur-5 promoter in pTG96 in VC2010 and
CF3152 animals.
VC2010
CF3152

FSN PCR/TG96
VC2010 FSN 5A1
VC2010 FSN 9C3
VC2010 FSN 3D1
CF3152 FSN 3B3
CF3152 FSN 3B5

pPD 49.83/TG96
VC2010 pPD 1D3
VC2010 pPD 4C2
VC2010 pPD 13B3
CF3152 pPD 3A1

Table 21: pnpt-1 Transgenic lines. FSN represented transgenic lines with the Fusion PCR
construct for exogenous PNPase expression. pPD represented transgenic lines with the pPD
49.83 empty vector control. Strains in bold were used in subsequent assays
Determination of Heat Shock Protocols
The Fusion PCR construct contains a hsp-16.41 promoter that can activate transcription
upon heat stress (Stringham et. al., 1991). Previous studies have identified the optimal
temperature range to activate transcription with adequate response was 29°C to 31°C. Heat shock
temperatures could be as low as 25°C but with only ~1% of cells showing activation of transgene
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expression (Stringham et. al., 1991). For the protocol, researchers have determined that two twohour exposures with a 30 minute recovery period at 20°C was ideal.
Our goal was to identify a temperature and protocol that would activate the hsp-16.41
promoter for ectopic expression of pnpt-1 without killing the nematode. The experiment
compared two protocols: heat shock at 30°C for two 2 hour intervals with a 30 minute recovery
period at 20°C and heat shock at 30°C for one 2 hour interval (Stringham et. al., 1992). We used
qRT-PCR to measure FLAG TAG expression for exogenous PNPase to compare the two
protocols. Both treatment conditions resulted in induction of exogenous PNPase expression. In
both VC2010 FSN 9C3 and CF3152 FSN 3B3 transgenic lines with the Fusion PCR construct,
there was a larger increasing trend for exogenous expression of PNPase with the two 2 hour
interval at 30°C compared to one 2 hour interval at 30°C. When compared to the values from one
2 hour heat shock interval, VC2010 FSN 9C3 resulted in a 318.6% increase and CF3152 FSN
3B3 resulted in a 90.6% increase with 2 intervals of heat shock (Figure 16). This was attempted
once for protocol determination only, thus no statistical analysis can be provided. Moving
forward, the heat shock protocol for subsequent overexpression experiments followed the two 2
hour interval at 30°C.
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Figure 16: Exogenous PNPase Expression Under Two Heat Shock Protocols. Transgenic
lines VC2010 FSN 9C3 and CF3152 FSN 3B3 produced higher expression of exogenous PNPase
with two two-hour intervals at 30°& when compared to one two-hour heat shock interval at 30°&.
With two two-hour intervals, VC2010 resulted in a 166x fold change and CF3152 resulted in a
112x fold change compared to their non-heat shocked counterparts (n=1)
Exogenous pnpt-1 Expression
While the transgenic strains visibly expressed the co-injection GFP maker under a
fluorescent microscope, qRT-PCR experiments measuring FLAG TAG expression for ectopic
PNPase would allow confirmation of successful creation of an overexpression model. Among
the three heat shocked VC2010 FSN PCR transgenic lines and one heat shocked CF3152 FSN
PCR transgenic line, all four presented an increase for FLAG Tag expression for exogenous
PNPase in comparison to their non-heat shocked transgenic controls. Heat shocked VC2010
FSN 5A1 had 130x higher expression, heat shocked VC2010 FSN 9C3 had 130x higher
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expression, heat shocked VC2010 FSN 3D1 had a 348x higher expression, and heat shocked
CF3152 FSN 3B3 had 161x higher expression. Statistical analysis concluded that VC2010 FSN
5A1 (p = 0.045), VC2010 FSN 9C3 (p = 0.006), and CF3152 FSN 3B3 (p = 0.012) strains
produced a significant increase in expression for exogenous PNPase while VC2010 FSN 3D1 (p
= 0.192) was not significant (Figure 17). In subsequent experiments and assays, VC2010 FSN
9C3 and CF3152 FSN 3B3 were selected as the two transgenic lines to use for overexpression
studies.
Transgenic lines for the empty vector control (pPD49.83) showed no fold change in
FLAG Tag expression when heat shocked lines were compared with their non-heat shocked
controls (data not shown). Transgenic lines VC2010 pPD 1D3 and CF3152 pPD 3A1 were used
as controls for future experiments and assays.

Figure 17: FLAG Tag Expression in Transgenic Lines. Significant increase in fold change
was determined for exogenous PNPase expression in heat shocked VC2010 FSN 5A1 (p =
0.045), VC2010 FSN 9C3 (p = 0.006), and CF3152 FSN 3B3 (0.012) when compared to their
non-heat shocked counterparts. Increase in FLAG Tag expression in heat shocked VC2010 FSN
3D1 was not significant (p = 0.192) (n=3)
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Total (Endogenous and Exogenous) pnpt-1 Expression
The next step was to determine the difference in total PNPase expression between FSN
and pPD transgenic lines that were heat shocked and not heat shocked. The goal was to identify
how much exogenous PNPase contributed to total PNPase expression. qRT-PCR was used to
measure total PNPase, both endogenous and exogenous, using primers spanning the junction of
exon 9 and exon 10 of pnpt-1. All heat shocked lines that contained the Fusion PCR construct
produced significantly more total pnpt-1 expression than non-heat shocked controls. Heat
shocked VC2010 FSN 5A1 had 57x increase, heat shocked VC2010 FSN 9C3 had 100x increase,
heat shocked VC2010 FSN 3D1 had 128x increase, and heat shocked CF3152 FSN 3B3 had
127x increase in total PNPase expression. Heat shocked FSN transgenic lines produced a
significant increase in fold change for total PNPase expression compared to non-heat shocked
FSN transgenic lines (p = 0.0004). Heat shocked CF2010 pPD 4C2 had 1.1x increase, heat
shocked VC2010 pPD 1D3 had 1.61x increase, heat shocked VC2010 pPD 13B3 had 1.11x
increase, heat shocked CF3152 pPD 3A1 had 1.27x increase, and heat shocked CF3152 pPD
5A1 had 1.01x increase in total PNPase expression. Heat shocked pPD transgenic lines fold
changes were not statistically significant when compared to their non-heat shocked pPD
transgenic lines (p = 0.79) (n=3) (Figure 18).
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Figure 18: Total pnpt-1 Expression in Heat Shocked Transgenic lines. All four transgenic
lines with FSN PCR constructs showed significant increase in total PNPase expression when
heat shocked (p = 0.0004). pPD transgenic lines showed no significant difference in pnpt-1
expression when heat shocked (p = 0.79) (n=3)
Exogenous PNPase Expression
Following qRT-PCR analysis for FLAG Tag expression in transgenic lines, the next step
was to determine if heat shock activation for exogenous PNPase expression resulted in
exogenous PNPase protein formation. Western blot analysis was carried out using FLAG TAG
M2 antibody to detect exogenous PNPase since the FSN construct contained a triple FLAG Tag
at the C-terminus. Results indicated that only FSN transgenic lines that were heat shocked
produced flag-tagged PNPase (Figure 19).
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Figure 19: Exogenous PNPase Expression. Heat shocked FSN Transgenic lines resulted in
exogenous PNPase protein production that was detected through a FLAG Tag antibody. The
vector control pPD did not show any exogenous PNPase expression (n=3).
Polycistronic Transcript Accumulation
To determine if increased expression of PNPase influenced polycistronic transcript
accumulation in the mitochondria, qRT-PCR was carried out measuring polycistronic transcript
accumulation using primers at the junction between the ctb-1 and COIII genes. Heat shocked
VC2010 FSN 9C3 produced an 165.5% (2.66x fold change) increase in polycistronic transcript
accumulation while heat shocked CF3152 FSN 3B3 resulted in a 75.6% (0.24x fold change)
decrease in polycistronic transcript accumulation when compared to their non-heat shocked
counterparts. Statistical analysis determined the results for heat shocked VC2010 FSN 9C3 (p =
0.0006) and CF3152 FSN 3B3 (P < 0.0001) were significant. Heat shocked VC2010 pPD 1D3
resulted in an 8% increase in polycistronic transcript accumulation (1.08x fold change) and heat
shocked CF3152 pPD 3A1 resulted in a 192% increase (2.92x fold change) but was not
significantly different than its non-heat shocked counterpart. Heat shocked empty vector pPD
transgenic polycistronic transcript accumulation were not significantly different than their non-
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heat shock counterparts for VC2010 pPD 1D3 (p = 0.7511) and CF3152 pPD 3A1 (p = 0.08)
(n=3) (Figure 20).

Figure 20: Polycistronic transcript accumulation in Heat Shocked Transgenic Lines. Heat
shocked VC2010 FSN 9C3 presented significant increase in polycistronic transcript
accumulation (p = 0.0006). Heat shocked CF3152 FSN 3B3 presented significant decrease in
polycistronic transcript accumulation (p < 0.0001). Heat shocked empty vector controls resulted
in no significant change for polycistronic transcript accumulation. (n=3)
Total Mitochondrial Transcript
Total mitochondrial transcripts were quantified using qRT-PCR by measuring the
expression of COIII. Heat shocked transgenic lines were compared with their non-heat shocked
counterparts. Heat shocked VC2010 FSN 9C3 produced a large trend for increased total
mitochondrial transcript while CF3152 FSN 3B3, VC2010 pPD 1D3, and CF3152 pPD 3A1
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resulted in small trends for increased transcripts (Figure 21). Due to technical errors with this
protocol, the experiment was attempted only once so no statistical analysis can be provided.

Figure 21: Total Mitochondrial Transcripts in Heat Shocked Transgenic Lines. Increased
trends in total mitochondrial transcripts was present in heat shocked transgenic strains. (n=1)
ROS Assay
Previous work in cell lines determined that overexpression of PNPase resulted in an
increase of ROS production as a result of induced senescence (Sarkar et. al., 2004). The purpose
of this experiment was to determine if overexpression of PNPase as a result of exogenous
PNPase activation could change ROS production in heat shocked transgenic nematodes. ROS
production was quantified using the Amplex Red kit that served as an assay for quantifying
peroxidase activity when !" #" , a reactive oxygen specie, was present. In a comparison between
heat shocked and non-heat shocked strains, most of the strains saw no varying trends in
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absorbance changes when strains were heat shocked with the exception of VC2010 FSN 9C3.
Heat shocked VC2010 FSN 9C3 saw a 50.4% decrease in ROS production, heat shocked
CF3152 FSN 3B3 saw a 2.6% increase in ROS production, heat shocked VC2010 pPD 1D3
resulted in an 8.77% decrease in ROS production, and heat shocked CF3152 pPD 3A1 resulted
in a 13.89% increase in ROS production. Statistical analysis for VC2010 FSN 9C3 (p = 0.19),
CF3152 FSN 3B3 (p = 0.95), VC2010 pPD 1D3 (p = 0.55), and CF3152 pPD 3A1 (p = 0.82)
determined the results to be not significant (n=3) (Figure 22).

Figure 22: ROS Production in Heat Shocked Transgenic Lines. Results between heat
shocked and non-heat shocked transgenic lines varied little across different transgenic strains.
Statistical analysis revealed no significant differences between treatment groups (VC2010 FSN
9C3 (p = 0.19), CF3152 FSN 3B3 (p = 0.95), VC2010 pPD 1D3 (p = 0.55), CF3152 pPD 3A1 (p
= 0.82) (n=3).
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Cancer Model Studies
The goal of the cancer model studies was to combine the PNPase overexpression model
in a gld-1 knockdown cancer model nematode and to determine if PNPase overexpression
differentiates cells into non-germline cells in the nematode germline

Heat Shock Protocol Optimization for Cancer Models
Protocol to heat shock transgenic worms was optimized for both temperature and
duration in order to produce exogenous PNPase expression over a 2-day period during
knockdown of gld-1 without killing the nematode. qRT-PCR measuring FLAG Tag expression
for exogenous PNPase in the CF3152 FSN 3B3 transgenic strain identified a suitable heat shock
protocol produced the most exogenous PNPase. Adult nematodes were heat shocked at 26.5°C
or 27.2°& for a 24-hour period or heat shocked at 30°C for two 2 hour intervals with a 30 minute
break at 20°C in between. Heat shock protocols at 26.5°C or 27.2°C resulted in an increased fold
change by 339X and 423X, respectively, but when the nematodes were heat shocked at 30°C
produced the highest fold change trend at 4564X (Figure 23). Statistical analysis could not be
conducted since this was attempted only once for protocol optimization. The final heat shock
protocol for subsequent gld-1 cancer experiments consisted of two 2 hour intervals at 30°C
separated by a 24 hour period between each interval.
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Figure 23: Exogenous PNPase Expression in Heat Shocked CF3152 FSN 3B3 strain. When
animals were heat shocked at 30°& there was an 4564X increase compared to their non-heat
shocked counterpart. Heat shocked the animals at 26.5°& or 27.2°& produced a smaller increase.
(n=1)
Oocyte Formation
gld-1 knockdown in C. elegans produces a cancer phenotype that results in massive
mitotic proliferation throughout the germline and ablation of oocyte production (Kirienko et. al.,
2014). Overexpression of PNPase induces a senescent-like phenotype that arrest cells in G1
phase of the cell cycle and inhibits growth in HO-1 cell lines (Sarkar et. al., 2003). The goal was
to determine if overexpression of PNPase prevents the gld-1 overproliferation phenotype through
senescent inducing mechanisms. gld-1 knockdown nematode strains were heat shocked, oocyte
production quantified and compared to their non-heat shocked control. There was no difference
in oocyte production with PNPase overexpression. Though heat shocked CF3152 FSN 3B3
resulted in a 8.47 increase in oocyte producing worms (p = 0.16), heat shocked CF3152 pPD
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3A1 resulted in a 25.19% increase (p = 0.16), and heat shocked CF3152 resulted in a 7.96%
decrease (p = 0.76), though there was no statistical difference (Figure 24).

Figure 24: Oocyte Production in Heat Shocked Animals. There was no difference in oocyte
production in both FSN, pPD transgenic lines or CF3152 controls when. Results were not
statistically significant (CF3152: p = 0.76, CF3152 pPD 3A1: p = 0.16, CF3152 FSN 3B3: p =
0.16) (n=3)
P-Granule Immunohistochemistry
The regulatory regions of the Fusion PCR construct consisted of the hsp-16.41 promoter
and the unc-54 3` UTR that allow expression in most somatic cells and within late pachytene of
the nematode germline. Knockdown of gld-1 not only creates a cancer model with mass mitotic
proliferation throughout the germline but also development of somatic cells such as muscle,
neuronal, and intestinal cells within the gonad (Ciosk et. al., 2006). K76, antibody to PGL-1,
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would detect p-granules through immunofluorescence, serving as a marker specific for germline
cells in the nematode gonad. Immunofluorescence of the germline would determine if
overexpression of exogenous PNPase would inhibit or reduce severity of gld-1 cancer phenotype
and increase the number of non-germline cells within the gonad through induction of senescence
or differentiation.
Strains used for immunofluorescence consisted of CF3152 with and without heat shock,
CF3152 pPD 3A1, and CF3152 FSN 3B3 with the same treatment. All gonads were co-stained
with K76 and FLAG Tag antibodies to detect germline specific cells and exogenous PNPase,
respectively. All six strains presented staining for K76, a marker that is targeting guanyl-specific
ribonuclease pgl-1 that is found exclusively in germline cells, from the distal to proximal end of
the germline (Figure 25-30), and no oocyte production with the exception of one case in CF3152
FSN 3B3 no heat shock (Figure 29). Exogenous PNPase expression was only observed in
CF3152 FSN 3B3 when it was heat shocked (Figure 30). Gonads in this heat shocked strain
displayed cells that presented FLAG Tag expression with no K76 colocalization. No staining for
K76 in those cells determined that those are non-germline cells. It was also determined that heat
shock treatment and empty vector pPD49.83 had no effect on the tumerous phenotype of the
gld-1 cancer model.
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Figure 25: Oocyte Development of gld-1 KD CF3152 Control Worms. Gonad of CF3152 no
heat shock at 20x magnification shows no oocyte formation in the proximal gonad (blue and
purple boxes_ with K76 staining present from distal to proximal in the germline (red through
purple boxes). No FLAG Tag staining indicates no exogenous PNPase expression (red through
purple boxes). Blue is DAPI staining, green is K76 and red is FLAG-tag PNPase (20x mag)
(n=1).
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Figure 26: Oocyte Development of gld-1 KD CF3152 with Heat Shock. Gonad of CF3152
with heat shock shows no oocyte formation in the proximal gonad (blue and purple boxes) with
K76 staining present from distal to proximal ends of the germline (red through purple boxes).
FLAG Tag PNPase staining was not detected indicating no exogenous PNPase expression (red
through purple boxes). Blue is DAPI staining, green is K76 and red is FLAG-tag PNPase (40x
mag) (n=3)
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Figure 27: Oocyte Development of gld-1 KD CF3152 pPD 3A1 no Heat Shock. Gonad of
CF3152 pPD 3A1 with no heat shock shows no oocyte formation (blue and purple boxes) in the
proximal gonad with K76 staining present from distal to proximal ends of the germline (red
through purple boxes). No FLAG Tag detection indicates no exogenous PNPase expression (red
through purple boxes). Blue is DAPI staining, green is K76 and red is FLAG-tag PNPase (40x
mag) (n=1)
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Figure 28: Oocyte Development gld-1 KD CF3152 pPD 3A1 with Heat Shock. Gonad of
CF3152 pPD 3A1 with heat shock shows a large cellular body with chromatin morphology
suggesting oocyte formation or meiotic division in the middle of the germline (light blue box).
K76 staining is present from distal to proximal ends of the germline with the exception of the
large body singular cell (red, yellow, green, purple boxes). No FLAG Tag detected indicating no
exogenous PNPase expression (red through purple boxes). Blue is DAPI staining, green is K76
and red is FLAG-tag PNPase (40x mag)(n=2)
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Figure 29: Gonad of gld-1 KD CF3152 FSN 3B3 Without Heat Shock. While oocyte
development appears to be replaced with mitotic divisions in the proximal region of gonad due to
gld-1 knockdown (red box), the proximal gonad contained a large mononuclear structure with no
K76 staining (blue and purple boxes). No FLAG Tag staining present throughout the germline
(red through purple boxes). Blue is DAPI staining, green is K76 and red is FLAG-tag PNPase
(20x mag) (n=4)
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Figure 30: Gonad of gld-1 KD CF3152 FSN 3B3 with Heat Shock. FLAG Tag staining (red)
was observed to be present in the germline (yellow and purple boxes). Cells within the region of
FLAG Tag staining did not present K76 staining (green) (yellow and purple boxes). At the
proximal end of the gonad (purple box), FLAG Tag staining appeared to localize around DAPI
stained DNA (blue). No oocyte formation was present in the germline (red through purple
boxes). K76 staining was present from the distal to proximal ends (orange through purple boxes)
with the exception of cells at the very distal tip of the germline (red box) and cells colocalized
with FLAG Tag expression for ectopic PNPase expression (yellow and purple boxes) (whole
germline = 20x mag | cut outs = 100x mag) (n=1)
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Chapter 4: Discussion
Phenotypic characterization of overexpression and knockout of PNPase has been restricted to
models such as cell lines or organ specific models, limiting the conclusions that can be drawn
with regard to the organism as a whole. Additionally, no whole animal model for PNPase
overexpression has been produced. Formation of an animal model for overexpression and
characterization of PNPase mutants, with the already synthesized knockdown model in C.
elegans (Lambert 2015), would allow direct comparison of the phenotypic effects of reduced and
increased PNPase levels on both a gross and molecular scale. Analysis of PNPase mutants
would determine if the selected missense mutations impair protein function and contribute to a
disease phenotype. Having these models would allow correlation of previous PNPase findings in
ROS, and mitochondrial homeostasis mechanisms and how they present in an animal model
setting. A model for PNPase overexpression would also allow investigation into associated
senescent inducing and differentiation mechanisms in a whole animal cancer model.
In this study, the first step was to create an overexpression and mutant models for PNPase in
C. elegans. Then, ROS production and mitochondrial homeostasis through polycistronic and
total mitochondrial transcript accumulation were measured in PNPase knockdown, mutants, and
overexpression. Qualitative analysis through immunofluorescence was utilized to observe the
influence of ectopic PNPase overexpression on germline tumor cells in a cancer model setting.

Knockdown Studies
RNAi mechanisms to knockdown gene expression in C. elegans produced a decrease in
PNPase expression but were inconsistent with each experiment when attempting to confirm
previous studies (see Appendix). When RNAi mechanisms did work, the results matched
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previous reports that noted a 63% reduction in mRNA expression (Lambert 2015).
Inconsistencies in achieving knockdown expression could have been attributed to not using the
freshest reagents, plates, and bacteria. However, even when using the freshest reagents and
stocks, knockdown of PNPase was only achieved 3 out of 6 times. Although inconsistent with
PNPase expression, knockdown of dpy-10 to produce the dumpy phenotype as a control was
consistently seen with each RNAi attempt. This suggests that the RNAi protocol is capable of
knocking down gene expression for dpy-10. Issues for Exon 3 knockdown could be inefficiency
of the IPTG inducer for activated transcription and production of dsRNA of Exon 3 or growth of
antibiotic resistance bacteria in the same RNAi culture, reducing the knockdown effect. A
previous report had indicated that despite using the most optimal RNAi technique for
knockdown expression (consumption of bacteria expressing dsRNA with 1mM IPTG inducer in
the plate media instead of bacteria culture), phenotypic variability of RNAi penetrance was
present for different gene targets (Kamath et. al., 2001). This could explain why dumpy
phenotype with knockdown of dpy-10 was consistent while knockdown of PNPase was not.
ROS were quantified as a means to determine PNPase effects on mitochondrial
homeostasis. In addition to ROS being produced as a byproduct of cellular respiration, aging
cells are associated with production of high levels of ROS from the mitochondria that cause
damage to protein, lipids, and DNA (Davali et. al., 2016). ROS mediates senescence through
accumulation of damage and contributes to the induction of replicative senescence, limiting the
number of divisions a cell can undertake (Chen et. al., 1998; Passos et. al., 2010). In addition to
onset of senescence, ROS also functions in a positive feedback loop mechanism to maintain the
senescent phenotype (Takahashi et. al., 2006). These findings suggest ROS plays a large role in
senescence.

104
Knockdown of PNPase resulted in an increased trend in ROS production (appendix) in
agreement with previous knockdown studies (Lambert 2015). Lack of significance of the results
could be attributed to inconsistencies in producing knockdown of PNPase through RNAi
mechanisms. Previous studies identified a near 50% increase in ROS production in knockdown
of PNPase compared to the control (Lambert 2015). While a large increase in ROS production
induced and maintained senescence, our findings presented a slight increase in ROS production
that could be attributed to activation of beneficial stress responses that influence extension of
lifespan. Additionally, a low increase of ROS can activate signaling pathways leading to
proliferation and transcription (Trachootham et. al., 2008; Thannickal and Fanburg, 2000).
Previous lifespan studies have reported that knockdown of PNPase resulted in an extension of
lifespan. It was hypothesized that the slight elevation of ROS production could have activated
beneficial stress responses to influence extension of lifespan (Lambert 2015). However, to
determine if this level of increased ROS imparted beneficial responses such as lifespan
extension, a lifespan assay comparing knockdown, mutants, and overexpression profiles of
pnpt-1 would be required.
Polycistronic and total mitochondrial transcripts were measured to assess the role of
PNPase in transporting RNase P RNA, an exoribonuclease responsible for processing
mitochondrial tRNAs, in the mitochondria. The mitochondrial genome is a circular piece of
DNA that is transcribed as a single polycistronic transcript where a single mRNA can code for
several proteins upon RNA processing. Amounts of both polycistronic and total mitochondrial
transcripts were determined through qRT-PCR. It was expected that our knockdown studies
would produce similar results as the previous knockdown studies with an increase in
polycistronic transcript accumulation. Knockdown of PNPase saw a decrease trend in both
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polycistronic transcripts and total mitochondrial transcripts but results were not significant.
Previous studies concluded that PNPase knockdown through RNAi mechanisms resulted in an
increase in polycistronic transcript by 66 fold. It was suggested that reduced expression of
PNPase would decrease the rate of transport of RNase P RNA to the mitochondria, leading to
increased accumulation of polycistronic transcripts due to improper splicing of mitochondrial
transcript (Lambert 2015). Even with confirmation of knockdown of PNPase expression, our
findings contradict previous studies. However, since our results were not statistically significant,
we were unable to conclude if polycistronic transcript accumulation decreases with knockdown
of PNPase. Results produced could be attributed to a reduced but functional level of PNPase
expression even though knockdown of PNPase expression occurred. The residual level of
PNPase expression could allow transport of RNase P RNA to the mitochondria, thus allowing
processing of polycistronic transcripts and a decrease in its accumulation.
For future directions, optimization of RNAi protocol could be carried out to improve
penetrance of the knockdown phenotype. Such changes could include increasing IPTG inducer
to 1 mM and adding it to the worm plate rather than in the bacterial cultures, and grow liquid
cultures without induction and allow seeded cultures to grow at room temperature (Kamath et.
al., 2001). Additionally, comparisons could be made between staging worms at the L4 stage
versus staging embryos to determine which protocol produces the greatest knockdown effect.

Mutant Studies
Previous studies of mutations in PNPase in cultured skin fibroblasts saw a 50-60%
decrease in PNPase protein but no change in PNPT1 transcripts (Vedrenne et al., 2012).
Researchers identified a disruption in the trimerization of the protein when the missense
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mutation was located in the second RNase PH catalytic domain (Vedrenne et. al., 2012). Our
findings were consistent with previous reports but were limited to pnpt-1 transcripts. We found
that pnpt-1 mRNA expression was unchanged in the mutants. We were able to conclude that
three specific missense mutations in the first RNase PH domain do not affect PNPase expression
since the mutations were located in the RNase PH domain and not in a regulatory region
associated with pnpt-1.
Mutant strains resulted in no significant change in ROS production compared to their
wildtype counterpart. Previous studies have noted that phenotypic effects from PNPase
mutations vary and severity of functional deficits of PNPase is dependent on the severity of the
mutation (Golzarroshan et. al., 2018; von Ameln et. al., 2012). One study noted that a p.E475G
missense mutation in human PNPase did not affect PNPase expression but resulted in a disease
phenotype consisting of hearing loss (von Ameln et. al., 2012). Our results proved that these
specific mutations in pnpt-1 produced no significant phenotypic change in ROS production,
suggesting that these mutations were not severe.
All three strains with mutations in the first RNase PH domain resulted in non-significant
changes in polycistronic transcript accumulation and mutant strains G58E and G74E resulted in
an increase trend for total mitochondrial transcripts. These findings suggested that certain
mutations in PNPase could vary in their contribution to mitochondrial homeostasis. Previous
findings of bacterial PNPase determined that the second RNase PH domain carried out most of
the catalytic activity of the protein, and mutations in the second domain resulted in a severe nonfunctional phenotype that impaired phosphorolysis, polymerization, and exchange (Jarrige et. al.,
2002). However, mutations in the first RNase PH domain did reduce specific activity of PNPase,
but not at the same severity or degree as the mutations in the second RNase PH domain (Jarrige
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et. al., 2002). Also, studies in human PNPase determined that both RNase PH domains
possessed similar phosphorylitic properties with equal enzymatic activity. Presence of either one
of them was sufficient for total enzymatic activity (Sarkar et. al., 2005). Our findings did agree
with previous studies. The results produced showed that mutations in the first RNase PH domain
do not contribute to significant increase in polycistronic transcript accumulation. This could
partly be due to the fact that the second RNase PH domain contained no mutations and
compensated phosphorylitic activity for the first mutated RNase PH domain. One study
identified a patient with two biallelic pathogenic missense variants in PNPT1 (R136C and
P467H), one in each RNase PH domain of PNPase (Rius et. al., 2019). When assessing PNPase
mitochondrial RNA processing activity, investigators reported that the patient’s fibroblasts
presented a significant increase in accumulation of unprocessed mitochondrial transcripts (Rius
et. al., 2019). Individual mutations could vary in degree of disrupting normal PNPase function
without altering PNPase expression even if they were located in the first catalytic domain.
However, conserved amino acids present in orthologs of PNPase could suggest a higher degree
of importance as determining residues. Mutations affecting these amino acids would be more
likely to impart a disease phenotype. Among the mutant strains selected, the G58E missense
mutation occurs at a conserved residue while G74R and G74E are missense mutations in an
unconserved residue. Despite this, all three mutant strains did not produce a significant change
in polycistronic transcript accumulation nor ROS production. As a result, we can conclude that
the studied mutations in pnpt-1 do not produce a deleterious phenotype within the areas of
polycistronic transcript accumulation, total mitochondrial transcript accumulation, and ROS
production.
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For future studies, using other mutant strains that contain missense mutations in the
second catalytic RNase PH domain would determine if both catalytic domains work equally or if
the second domain carries out most of the enzyme activity. Additionally, there is another mutant
strain that has a missense mutation in the S1 RNA binding domain of pnpt-1. Using this strain
would determine if the mutation affects RNA binding activity of PNPase and if that change leads
to observable phenotypic effects. Also, CRISPR could be used to knock in human mutations at
conserved residues in wPNPT1 such as A510P and Q387R in the human studies. Doing so could
determine if similar phenotypes seen in human studies would be present in C. elegans. Using
only Polyphen-2 and SIFT for predicted effects of mutations limited our knowledge of the effect
the missense mutations had on protein catalytic function. Having protein structure analysis
would give insight on the structural changes occurred and if those changes inhibit normal protein
function. Non denaturing or native gel electrophoresis would also determine if those mutations
affected trimerization of the protein.

Overexpression Studies
Creation of an overexpression model for PNPase first required design and synthesis of
the transgenic construct. Initial attempts at cloning PNPase into the pPD49.83 vector were not
successful and it is likely that certain cloned fragments of pnpt-1 were toxic to transformed
bacteria. Varied attempts consisted of adjusting different steps of the cloning protocol to bypass
this issue. Different competent cells, BL21 DE3, ABLE C, and ABLE K, were used for their
specific properties at retrieving clones that were toxic to E. Coli since initial cloning attempts
with DH5alpha and DH10B were unsuccessful leading us to hypothesize that the fragment being
cloned was toxic to the bacteria. ABLE C and ABLE K strains are designed to increase the
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probability of retrieving toxic clones by reducing the plasmid copy number. This results in
decreased levels of the cloned gene product and enhances the probability for toxicity to the host.
BL21 DE3 cells have T7 RNA polymerase controlled by Lac regulatory construct that will only
be active in the presence of IPTG, thus limiting toxic protein expression. Temperature
conditions were lowered and transformed bacteria were grown at room temperature (20°C - 30°C)
for several days to reduce toxicity of the hypothetically toxic cloned gene. Any attempt at
cloning a 3` fragment of pnpt-1 resulted in the fragment ligating in the opposite orientation or
ligating in the correct orientation but with mutations. A third party manufacturer (ThermoFisher
GeneArt Gene Synthesis) was used to design a fragment of pnpt-1 hypothesized to be toxic to E.
coli. While they were able to clone the fragment and synthesize the plasmid, using that pnpt-1
fragment for subsequent ligating and cloning protocols was unsuccessful. Gibson assembly
protocol was also used to minimize the number of cloning and transformation steps but also
failed. As a result, we conclude that the 3` fragment is toxic to E. coli, thus preventing
successful cloning of this gene. PCR Fusion allowed for annealing of overlapping ends between
multiple individual segments and using a two-step method to create the full-length clone (Hobert
et. al., 2002; Luo et. al., 2012). It was vital to use a polymerase with 3` - 5` proofreading activity
and high fidelity to fix and prevent, respectively, sequence errors during each amplification cycle
(Hobert et. al., 2002). This technique allowed for bypassing of intermediate steps associated
with cloning such as overnight cultures, mini-preps, and transformations. As a result, generating
the full-length clone in vitro did not require the construct to be propagated in E. coli. This
ultimately streamlined the assembly process.
Overexpression of PNPase was achieved through heat shocked protocols at two hour
intervals at 30°C for exogenous PNPase expression. A combination of qRT-PCRs and Western
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blots allowed identification and differentiation of exogenous PNPase from endogenous PNPase
due to the added 3X FLAG Tag in the Fusion PCR construct. We determined that transcription
activation only occurred at a certain temperature and degree of expression correlated with
increasing temperature. Also, heat shock activation led to protein formation of exogenous
PNPase. Activation the hsp-16.41 promoter minimally required a temperature of 29°C to 31°C
while temperatures as low as 25°C saw a little as 1% of cells staining (Stringham et. al., 1991).
Additionally, transgenic nematodes maintained at 20°C results in no transgenic expression (Bacaj
et. al., 2007). Our findings matched these predictions and demonstrated that heat shocked at
30°C activated the hsp-16.41 promoter for transcription of ectopic pnpt-1 that eventually led to
exogenous protein formation. If there was no heat shock or if a certain temperature threshold
was not reached, the promoter would not activate and transcription would not occur.
Additionally, no leakage of ectopic expression could be detected when samples were not
heashocked. Successful activation of the hsp-16.41 produced increased expression levels of
exogenous PNPase, thus contributing to elevated levels of total PNPase expression. Also, these
findings concluded that heat shocked protocols saw no significant influence in changing
endogenous PNPase expression.
When pnpt-1 was induced to be overexpressed, quantification of ROS production saw no
significant difference in any of the transgenic strains. Previous findings determined
overexpression of hPNPase resulted in an increase in ROS production (Sarkar et. al., 2004).
Overexpression of PNPase also led to a senescent like growth arrest phenotype with elevated
levels of ROS being vital for induction and maintenance of the cell senescence process (Sarkar
et. al., 2004; Davalli et. al., 2016). Our results did not agree with previous findings and
suggested that the degree of overexpression of PNPase was not sufficient enough to induce a
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senescent-like phenotype that would lead to an increase in ROS production. One potential
complication with this experiment is that the pnpt-1 overexpression transgene is not present in
every cell preventing uniform expression of PNPase throughout the nematode body and instead
resulting in a more mosaic pattern of expression. Although the transgenic lines proved to be
stable, extrachromosomal arrays, such as the microinjected Fusion PCR construct, can be
unstable to cell division with varying degrees of mitotic instability and incomplete inheritance
(Evans et. al., 2006). Specifically, some of the disadvantages of creating extrachromosomal
arrays through microinjection are difficulty in predicting and controlling the level of expression,
variable expression among siblings of a single strain, and variable expression due to mitotic
instability of the arrays (Evans et. al., 2006). As a result, lack of uniform exogenous PNPase
overexpression in the transgenic models would prevent induced senescence in every cell.
Finally, we could not be seeing the same results as previous studies due to not running enough
trials. A different approach to allow uniform expression of exogenous wpnpt-1 in all cells and
consistent inheritance with each generation of progeny would be to use CRISPR to insert the
Fusion PCR construct in the C. elegans genome in a region that does not disrupt any endogenous
gene function.
When pnpt-1 was overexpressed, wildtype transgenic lines (VC2010) resulted in an increase
in polycistronic transcript accumulation while rrf-3 mutant transgenic lines (CF3152) saw a
decrease when compared to their non-heat shocked counterparts. Total mitochondrial transcripts
presented elevated trends in heat shocked wildtype and in heat shocked rrf-3 mutants. Despite
producing similar trends in total PNPase and exogenous PNPase expression, opposite results
between transgenic wildtype and rrf-3 mutants could be due to CF3152 strains containing a rrf-3
deletion. The rrf-3 gene codes for an RNA dependent RNA polymerase that is involved in
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chromatin silencing by small RNA and spermatogenesis. While the rrf-3 deletion is often
associated with temperature sensitivity in regards to sterility and fertility, and enhanced RNAi
(Han et. al., 2009), deletion of this gene could also be imparting some phenotypic effect that
leads to decreased polycistronic transcript accumulation in conjunction with overexpression of
PNPase. Heat shock treatment to already temperature sensitive rrf-3 mutant strains to activate
exogenous PNPase expression could influence the onset of additional phenotypes beyond what is
already known.

Temporal Regulation of PNPase Expression in the Germline
Exogenous PNPase expression was only detected in the nematode when the transgenic
worm was heat shocked. Immunofluorescence labeling for FLAG Tag in gonads for exogenous
PNPase resulted in staining only in CF3152 FSN 3B3 transgenic worms after heat shock
activation in the pachytene region of the nematode gonad. Our findings matched our
expectations that hsp-16.41 and unc-54 3` UTR both served as transcriptional and posttranscriptional regulators that limit expression to a specific region of the gonad. The
combination of both the promoter and UTR spatially controlled expression of exogenous PNPase
in cells, limiting it to cells in the late pachytene region of the gonad. Previous studies had
indicated that the hsp-16.41 promoter was expressed in most somatic cells with a higher
incidence of expression in intestinal and pharyngeal tissue so was not germline specific (Merrit
et. al., 2010). In addition to staining in the nematode gonad, intestinal cells stained brightly for
FLAG Tagged exogenous PNPase expression, matching with previous reports (data not shown).
Unpublished data had observed weak expression in late pachytene of gametogenesis from the
hsp-16.41 promoter (Merritt et. al., 2010; Bacaj et. al., 2007). The unc-54 3` UTR restricts
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expression to all germ cells (Merritt et. al., 2008). These reports on spatial influence of
transcriptional regulators were consistent with our findings of predictions of PNPase expression
in the middle region of the gonad, approximately where pachytene occurs.
Although FLAG Tag expression for exogenous PNPase was consistent with each attempt,
the polyclonal antibody used created so much background in the gonad that it interfered with
image quality. It led to concerns that staining the germline was an artifact and not a positive
result. However, it was confirmed that the staining for exogenous PNPase in the germline was
not an artifact after a monoclonal FLAG Tag antibody produced similar results (data not shown).
PNPase Senescence or Differentiation in the Germline
The goal of this study was to determine if overexpression of ectopic PNPase in the
germline would result in induction of senescence or differentiation of germline tumor cells.
Immunofluorescence labeling for germline specific P granules and exogenous PNPase identified
cells in the gld-1 cancer model that expressed exogenous PNPase but did not present P granule
staining. All six groups presented successful cancer phenotype formation with knockdown of
gld-1. Gonads resulted in mass mitotic proliferation from the distal to proximal end of the
germline with no oocyte production. Previous studies have indicated that knockdown or
mutation of gld-1 results in brief entry of germline cells into meiosis but quickly reverting to
mitotic proliferation. As a result, no oogenesis nor oocytes were produced with mitotically
proliferating cells taking its place (Kirienko et. al., 2014). These reports were consistent with
our findings and allowed us to conclude that gld-1 results in mitotic proliferation from distal to
proximal ends of the germline with no oocyte development.
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Only heat shocked CF3152 FSN 3B3 nematodes presented staining for exogenous
PNPase in the middle of the gonad. Specifically, cells that contained exogenous PNPase did not
present P granule staining suggesting terminal differentiation of a germline tumor cell into a nongermline cell. PGL-1, or P granules, is a germline specific marker that is essential for fertility in
C. elegans (Kawasaki et. al., 1998, Nayak et. al., 2004). Previous studies had noted that
knockdown of gld-1 resulted in development of non-germline cells in the nematode gonad.
Specifically, 40% of gonads presented both differentiated neuronal and muscle cells and 55% of
gonads presented differentiated neuronal cells in germline of 1.5 day adults. When differentiated,
the cells lost P granule expression with the nuclei not resembling germline cells (Ciosk et. al.,
2006). While the nuclei formation could not be observed to differentiate somatic and germ cell
nuclei, these reports were consistent with our finding that exogenous PNPase induces
differentiation into a non-germline cell. However, the type of differentiated cell, whether it was
a neuronal or muscle-like cell, could not be determined. Antibodies and markers used limited
our scope to only determining if the cell belonged in the germline or not. Also, high
concentration of cells as a result of the gld-1 knockdown cancer phenotype prevented individual
cellular analysis of nuclei morphology. Based on this, we proposed that ectopic overexpression
of PNPase has a role in differentiation inducing mechanisms in a tumor setting.
While the initial data look promising, additional attempts need to be carried out to
determine a consistent and significant result. Additionally, our experimental design allows us
only to determine if germline cells differentiated into non-germline cells. It does not allow
confirmation if the differentiated cells are senescing or not. While long term exit from the cell
cycle is the main marker for cellular senescence, terminal differentiation results in replicative
arrest triggered by physiological cues while cellular senescence withdraws from the cell cycle as
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a result of activation of tumor suppressor networks and other associated factors (Kuilman et. al.,
2010). Another encountered shortcoming occurred when using gld-1 knockdown cancer models.
The gonads of these models were extremely brittle and prone to bursting and ripping upon
dissection. Also, the cancer model gonads had a greater tendency to wash off the Poly-L-Lysine
coated slides than wildtype gonads. Analyzing and locating individual cells in the proximal
region of the gonad for differentiated non-germline cells proved to be unfeasible. Large
concentrations of mitotically dividing cells prevented individual cellular analysis, making it
difficult to determine if P granule staining was present or not.
For future cancer model experiments, using the double knockdown cancer model, gld-1
and mex-3 in N2 worms has been reported to produce a higher incidence of non-germline cells
compared to only gld-1 knockdown worms (Ciosk et. al., 2006). Using the V2010 FSN 9C3
transgenic line, strain synthesized from the N2 wildtype derivative, with gld-1 and mex-3
knockdown should produce a modest over proliferation phenotype rather an extreme one that
inhibited individual cellular analysis. Rather than solely relying on K76, P granule antibody, to
differentiate between non-germline and germline cells, using antibodies for UNC-119 or HLH-1
would allow detection of neuronal or muscle like cells, respectively. This would provide
quantifiable results and determine if overexpression of PNPase induces a higher incidence of
non-germline cell differentiation.
Since hsp-16.41 expression was greatest in intestinal and pharyngeal tissue, using a
cancer model that causes hyperplasia in those tissues would be advantageous. Such cancer
models include lin-35;fzr-1 double mutants, and gain of function mutations in cdc-25.1 for
hyperplasia in intestinal tissue (Kirienko et. al., 2014). Rather than relying on higher heat shock
temperatures and the associated risk of killing the worms, it would be easier to achieve higher
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levels of exogenous PNPase in these tissue regions with the current heat shock protocol.
Examples of protocols include heat shock treatment at 33°C for two 2 hour intervals with a 30
minute break at 20°C inbetween (Stringham et. al., 1992) or 34°C for 30 minutes (Bacaj et. al.,
2007). Reports for the second protocol indicated presence of the transgene product up to 24
hours post heat treatment (Bacaj et. al., 2007).

Additional Future Directions
Future directions for phenotypic analysis of varied PNPase expression would include
optimizing current protocols and adding new ones. For current protocols, qRT-PCR for
polycistronic transcript accumulation and the ROS assay require optimization. Designing and
testing new primer designs for the ctb-1 and COIII junction to measure polycistronic transcripts
would determine if the machine errors are a result of primer design. For the ROS assay,
increasing the number of worms per sample to 100 would allow direct comparison with the
previous studies. Ultimately after optimization, multiple trials, or a minimum of three trials, of
each experiment need to be performed to allow statistical analysis.
Other experiments to analyze phenotypic effects from varied PNPase expression would
include analysis of mitochondrial morphology, identification of markers of senescence in
nematode, and quantification of 8-hydroxyguanin (8-oxoG) RNA molecules to correlate PNPase
and its role in protecting against oxidative stress. Analysis of mitochondrial morphology would
allow more correlations to be drawn between PNPase expression and mitochondrial homeostasis.
Also, it would allow direct comparison with previous knockdown studies. Although
overexpression of exogenous PNPase is confirmed, using markers for senescence would assess
the senescent inducing phenotype associated with PNPase such as age-dependent increased
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expression of lysosomal enzymes, acid phosphatase, beta-N-acetyl-D-glucosaminidase, beta-Dglucosidase, and alpha-D-mannosidase (Bolanowski et. al., 1983).
Rather than solely quantifying ROS, recent studies in Escherichia coli have identified
PNPase to function as a protector against oxidative stress. PNPase specifically binds to synthetic
RNA containing oxidative lesions called 8-oxoG, suggesting a role in removing oxidative
damage (Wu et. al., 2009). 8-hydroxyguanine is an oxidized form of guanine that has potential
to pair with both adenine and cytosine at equal efficiencies, causing translational errors if this
molecule was present in messenger RNA. Additionally, 8-oxoguanine can cause mispairing
during DNA synthesis (Hayakawa et. al., 2001). RNA oxidation can be quantified to determine
the degree of accumulated oxidative damage in each expression profile of PNPase. These
experiments will provide better insight on PNPase function and association with mitochondrial
homeostasis.
In addition to identifying phenotypes associated with varied expression and mutation of
PNPase, further experiments can be carried out to investigate molecular mechanisms of PNPase
on these phenotypes. RNA-seq can be used with different expression profiles of PNPase to
analyze the C. elegans transcriptome of gene expression patterns encoded within RNA to
identify which genes are differentially expressed and are influenced by PNPase. Coimmunoprecipitation for protein-protein interactions can be used to determine if mutations in
PNPase affect protein binding activity to helicase SUV3, which forms a complex to carry out
mitochondrial RNA surveillance. Immunofluorescence can also be used to determine if
localization of PNPase is affected within a cell when the protein is overexpressed, knocked
down, or mutated.
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Chapter 5: Conclusion
The mutant studies confirmed that different functional deficits of PNPase is dependent on
the severity of the mutation. For our specific mutant strains, results suggest that these mutational
changes do not affect PNPase function. Although PNPase expression was not altered in strains
containing the mutation, the mutation appeared to not have contributed to protein function within
the realms of ROS production, and polycistronic and total mitochondrial transcript accumulation
with all mutant studies data presenting non significant results. For knockdown studies, trends
observed with ROS production was similar with previous studies. However, inconsistencies and
contradictions with previous data in regard to polycistronic transcript accumulation require
further optimization and testing to determine a significant trend. Our studies have produced a
stable transgenic overexpression model for PNPase that presented exogenous PNPase expression
in transgenic lines upon heat shock activation. In a cancer setting with this model, germline cells
expressing ectopic PNPase did not present P granule staining, suggesting differentiation into a
non-germline cell type. This finding expands on the differentiating inducing mechanisms
associated with PNPase. Although much of the data was not statistically significant, creation and
confirmation of a working overexpression animal model for PNPase provides a strong
foundation in better understanding protein functions, and its role in cancer.
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Appendix: Supplementary Protocols and Information

NGM Plates (Nematode Growth Media)
To a flask, 1.5 g of NaCl, 1.25 g of BactoPeptone (Difco), 8 g of BactoAgar (Difco), and
500 mL of ddH20 were added and autoclaved to sterilize the reagents. Additional reagents of
12.5 mL of 1M K3PO4 pH 6.0, 0.5 mL of CaCl2, 0.5mL of MgSO4, and 0.5 mL of 5 mg/mL
Cholesterol were added to the autoclaved NGM solution. NGM media was poured by hand into
60 mm x 15 mm medium plates and allowed to solidify at room temp prior to long term storage
in 4°C.
For NGM Carbenicillin Plates, 1 mL of 50 mg/mL filter sterilized carbenicillin was
added to the autoclaved 0.5 L of NGM media prior to pouring into 60 mm x 15 mm plates to
bring the final concentration of carbenicillin at 0.1 mg/mL.
Gels for western
Reagents
30% acrylamide/0.8%
bisacrylamide
4X Tris-HCl/SDS pH 8.8
4X Tris-HCl/SDS pH 6.8
ddH20
10% APS
TEMED

7.5% Acrylamide Resolving
Gel
2 mL

3.9% Acrylamide Stacking
Gel
0.52 mL

2 mL
N/A
4 mL
30 uL
6 uL

N/A
1 mL
2.48 mL
14 uL
4 uL

M9 Buffer
M9 consisted of 3 g KH" PO+ , 6 g Na" HPO+ , 5 g NaCl, 1 mL 1M MgSO+ , and H20 to 1
litre.
1X Transfer Buffer
1X Transfer Buffer consisted of 50 mL of 10X Transfer Buffer (15.2 g of Tris, 72.1 g of
Glycine, 5.0 g of SDS, and ddH20 to 500 mL), 150 mL of methanol, and 300 mL of ddH20.
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Knockdown Studies of PNPase in C. elegans
The goal for the knockdown studies of decreased expression of PNPase was to confirm
previous results, expand the findings, and observe how they compared to overexpression and
mutant studies of PNPase.
PNPase Expression
Knockdown of PNPase was generated through an RNAi clone (Exon 3), that spanned the
region from 5` of exon 1 through exon 3. Previously knockdown of PNPase through RNAi
resulted in a 63% reduction of mRNA and a 58% reduction in protein levels (Lambert 2015).
PNPase expression was measured using a qRT-PCR protocol for PNPase expression at the exon
9 and exon 10 junction. Six replicate qRT-PCRs were performed to measure PNPase expression
and the fold change results are listed as follows: Exon 3 (a) produced 0.36x (64% reduction),
Exon 3 (b) produced 1.44x (44% increase), Exon 3 (c) produced 1.03x (3% increase), Exon 3 (d)
produced 0.25x (75% reduction), Exon 3 (e) produced 1.03x (3% increase), and Exon 3(f)
produced 0.74x (26% reduction) (Figure 31). Worms from samples a, d, and f were used for
measuring polycistronic transcript accumulation for Figure 33. The results from this experiment
identified issues with the knockdown model that required troubleshooting.
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Figure 31: pnpt-1 expression of Knockdown Samples. Exon 3 knockdown produced
inconsistent knockdown results: (a) 0.36x (64% reduction), (b) 1.44x (44% increase), (c) 1.03x
(3% increase), (d) 0.25x (75% reduction), (e) 1.03x (3% increase), and (f) 0.74x (26%
reduction). L4440 served as the empty vector control (n=6)
Polycistronic Transcript Accumulation
Previous work with PNPase knockdown samples resulted in an increased trend in
polycistronic transcripts with knockdown of PNPase expression (Lambert 2015). The goal was
to verify previous results after confirming samples had decreased expression of PNPase through
RNAi. qRT-PCR for PNPase expression determined knockdown of PNPase expression prior to
measuring polycistronic transcript accumulation with a statistically significant 45X fold change
in Exon 3 (55% knockdown) (p = 0.02) (Figure 32). Knockdown samples used for measuring
both PNPase expression and polycistronic transcript accumulation included knockdown samples
a, d, f. Polycistronic transcript accumulation was quantified using qRT-PCR protocols that
measured expression using primers that amplified the ctb-1 and COIII junction. Exon 3,
knockdown of PNPase, resulted in a decreased trend for polycistronic transcripts with an 86.1%
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decrease compared to L4440 control (Figure 33). Statistical analysis could not be carried out
since technical difficulties limited this experiment to two working attempts with samples a and d.

PNPase Expression
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Figure 32: PNPase Expression in Knockdown Samples a, d, f. Exon 3 knockdown results in a
0.45x (55% decrease) fold change in PNPase expression.(p = 0.02) (n=3)

Figure 33: Knockdown of PNPase. Exon 3 knockdown (Samples a and d) results in a decrease
trend for polycistronic transcript accumulation. (n=2)
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Total Mitochondrial Transcripts
Total mitochondrial transcripts were quantified using qRT-PCR by measuring the
expression of COIII. The COIII gene was used since it includes the ctb-1 and COIII junction
that was used to quantify the polycistronic transcripts. Knockdown of PNPase resulted in a
decrease trend in total mitochondrial transcripts with a 37% decrease compared to the L4440
control. Due to technical issues with this experiment, the experiment was only conducted once
and no statistical analysis could be carried out (Figure 34).

Figure 34: Total Mitochondrial Transcripts in Knockdown Animals. Knockdown of PNPase
(Exon 3) produced a decreased trend in total mitochondrial transcripts. (n=1)
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ROS Assay
Previous work studying knockdown of PNPase in C. elegans had identified a significant
increase in ROS production (Lambert 2015). To reconfirm the findings, ROS production was
measured in both knockdown (Exon 3) and control (L4440) strains. Knockdown of PNPase was
initially confirmed through qRT-PCR prior to running the assay with two out of the three Exon 3
samples showing decreased expression of PNPase (samples d and f). Knockdown samples used
for this assay consisted of samples d, e, and f. As a result, Exon 3 presented a 0.67x fold change
(32.5% decrease) in PNPase expression compared to L4440 control but was not statistically
significant (p = 0.22) (n=3)(Figure 35). Knockdown of PNPase (Exon 3) displayed an increased
trend for ROS production compared to the control, matching previous results. However,
statistical analysis determined the result to be not significant (p = 0.20) (n=3)(Figure 36).

Figure 35: PNPase expression in RNAi strains associated with ROS Assay. Exon 3,
knockdown of PNPase, shows a decreased trend for PNPase expression but was determined to be
non-significant (p = 0.22) (n=3)

133

Figure 36: ROS Production in Knockdown Animals. Knockdown of PNPase (Exon 3) showed
no difference in ROS production compared to the control (L4440) (p = 0.20)(n=3)
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Figure 37: Total PNPase Expression of all 3 expression profiles of PNPase
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Figure 38: Polycistronic Transcript Accumulation from all 3 expression profiles of PNPase.
(Knockdown samples, Exon 3 and L4440, were obtained from RNAi samples of ROS Assay and
RNAi trouble shooting experiments.)(n=3)
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Figure 39: Total Mitchondrial Transcripts from all 3 expression profiles. (n=1)
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Figure 40: ROS Assay for all 3 expression profiles of PNPase (n=3)

